最新刊期

    30 23 2024
    • 据报道,中国中医科学院中药研究所在中药药理学科发展和研究生课程体系建设方面取得显著成就,为提高研究生培养质量和推动学科发展提供参考。
      LIU Tuo,ZHANG Yanqiong,TANG Shihuan,LI Zhiyong,WANG Shan,LIU Baohua,BAI Yu,LI Yujie
      Vol. 30, Issue 23, Pages: 3-7(2024) DOI: 10.13422/j.cnki.syfjx.20241437
      摘要:Traditional Chinese medicine (TCM) pharmacology (PTCM) is a discipline that studies the interactions between Chinese medicines and the human body, as well as their underlying mechanisms, under the guidance of TCM theories while employing modern scientific techniques and methods. This article reviews the historical development and achievements of the PTCM discipline at the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, and outlines the reform measures undertaken in recent years to advance the construction of the graduate course system in PTCM. Building upon the foundation of the "Special Topics in PTCM" course, the curriculum has been expanded through reforms to include a series of self-designed courses, such as foundational advanced courses, experimental pharmacology courses, pharmacological research tools courses, and applied TCM research courses. Along with enriching the graduate course system, the study explores innovative approaches and methods for graduate education and teaching in PTCM, and reflects on the challenges in course system construction and teaching, serving as a reference for improving the quality of graduate training, promoting the development of the PTCM discipline, and advancing teaching reform practices.  
      关键词:major in traditional Chinese medicine pharmacology;graduate education;curriculum system construction;Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences   
      17
      |
      9
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74698359 false
      发布时间:2024-11-01
    • 中国中医科学院中药研究所中药药理学学科研究稳步发展,学科成员学术影响力良好,专利成果丰富,为中药现代化提供支持。
      ZHANG Lin,DENG Yuhan,LI Yanwen,QIU Luming,MA Sijia,LIU Tuo,LI Zhiyong,LI Yujie
      Vol. 30, Issue 23, Pages: 8-18(2024) DOI: 10.13422/j.cnki.syfjx.20241508
      摘要:ObjectiveTo analyze the literature related to traditional Chinese medicine (TCM) pharmacology of Institute of Chinese Materia and Medica, China Academy of Chinese Medical Sciences (hereinafter referred to as "Institute of Chinese Materia and Medica"), and evaluate the research status, development trend, influence of discipline members, and patent technology of this field.MethodThe papers from 2002 to 2024 in the databases of CNKI and Web of Science (WOS) were searched, whose first authors or corresponding authors are from the Institute of Chinese Materia and Medica, and CiteSpace 6.3.R6 was adopted for visual analysis of the annual number of publications and keywords. Additionally, the total number of published papers, citation times, and other measurement parameters of discipline members of TCM pharmacology in the institute were counted. After obtaining the h index, the academic track was calculated, and the academic influence of discipline members was quantitatively evaluated from the aspects of the academic track T and highly cited papers. Meanwhile, patent data from 2005 to 2024 of TCM pharmacology in the studied institute were retrieved from the HimmPat patent database, and Excel 2022 and Origin 2021 were utilized to conduct visual analysis on the overall patent application trend and technology composition.ResultIn the past 20 years or more, the annual publication of academic papers has been on the rise generally, and the key words include "animal model", "mechanism of action", "network pharmacology" and so on. The studies focus on the innovative methods of TCM pharmacological mechanisms, basic research on TCM prevention and treatment of major non-infectious diseases, and the prevention and treatment of respiratory viral diseases. The academic track T of the discipline members of TCM pharmacology in the Institute of Chinese Materia and Medica is positive, with sound personal influence. In recent years, the patent application trend has increased significantly, mainly concentrating on A61K patents and G01N subcategories, and IPC large-group analysis shows that the main technical applications are mainly in A61K36, A61K31, and other fields.ConclusionTCM pharmacology in the institute develops steadily and the academic influence of the discipline members is still sound, with fruitful patent achievements. In the future, research on pharmacological discipline innovation and new drug research and development can be enhanced, and multidisciplinary integration studies should be carried out to promote TCM modernization.  
      关键词:traditional Chinese medicine (TCM) pharmacology;bibliometrics;academic track;patent analysis;development trend   
      15
      |
      7
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74718673 false
      发布时间:2024-11-01
    • 在中药药理学领域,专家探讨了基于五脏关联规律的中药复方“同治/同调”药效优势挖掘路径,为中药复方药效评价方法学突破提供新思路。
      LI Yujie,LIU Tuo,WANG Luqi,CHEN Lina,LIANG Yan,LIU Chengcheng,LI Yu,ZHU Xiaoxin
      Vol. 30, Issue 23, Pages: 19-26(2024) DOI: 10.13422/j.cnki.syfjx.20250393
      摘要:The clinical efficacy advantages of traditional Chinese medicine (TCM) compound prescriptions have always been inadequately characterized in experimental research,which has become a bottleneck restricting the development of TCM pharmacology and even the progress of TCM. The concept of simultaneous treatment/regulation,guided by the theory of mutual generation and restriction of five zang-organs,has guiding significance in the clinical practice of TCM throughout history and is still widely used in the current clinical practice. However,this unique and clinically valuable diagnostic and therapeutic medication system based on the syndrome differentiation has been completely ignored in the modern research of TCM pharmacology,which might be one of the key factors restricting the pharmacological characterization of the therapeutic advantages of TCM compound prescriptions. On the basis of systematically summarizing the phased progress and achievements of the efficacy evaluation of TCM compound prescriptions,this article explores the path of exploring the pharmacological advantages of TCM compound prescriptions on simultaneous treatment/regulation on the basis of the correlation patterns of five zang-organs,from the theory of Zangxiang,the core concept of five zang-organs,and the TCM disease recognition based on the theory of mutual generation and restriction of five zang-organs. With the heart-lung correlation as a breakthrough point,this study explored a new characterization method for the pharmacological advantages of TCM,aiming to provide new ideas for evaluating the efficacy of TCM compound prescriptions.  
      关键词:efficacy evaluation of traditional Chinese medicine;theory of Zangxiang;five Zang-organs;simultaneous treatment;heart-lung correlation   
      14
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74686098 false
      发布时间:2024-11-01
    • 在心血管疾病防治领域,研究团队基于“气血交互于脉”理论,探讨了益气活血中药对心肌缺血再灌注损伤的防治机制,为临床应用中医药防治心血管疾病提供新思路。
      PENG Han,XIN Gaojie,CAO Ce,GUO Fan,LI Lingmei,FU Jianhua
      Vol. 30, Issue 23, Pages: 27-34(2024) DOI: 10.13422/j.cnki.syfjx.20242222
      摘要:Myocardial ischemia-reperfusion injury (MIRI) is a common injury in the treatment of ischemic heart diseases. MIRI can be categorized as chest impediment and palpitation in traditional Chinese medicine, with the pathogenesis related to Qi and blood disharmony. The simultaneous disorders of Qi and blood are the key mechanism of MIRI, and thus the differentiation of Qi and blood syndromes is the prerequisite for the treatment. The theory of Qi and blood interacting in vessels is proposed by our team based on Qi being the commander of blood and blood being the mother of Qi as well as previous pharmacological studies. Specifically, Qi marshals blood by vessels, and the blood carries Qi by vessels. Accordingly, Qi and blood interact in the vessels. MIRI is accompanied by mitochondrial dysfunction, platelet function abnormality, and vascular endothelial damage, which are correlated with Qi deficiency, blood stasis, and vessel damage, respectively. Mitochondrial, platelet, and vascular endothelial structural and functional changes triggered by their interactions are one of the mechanisms by which Qi deficiency, blood stasis, and vessel damage lead to the occurrence and development of MIRI. By exploring the correlations between Qi and mitochondria, between blood and platelets, and between vessels and blood vessels, we can explain the modern scientific content of the theory of Qi and blood interacting in vessels in traditional Chinese medicine. According to the pathogenesis of Qi and blood disharmony in vessels, we discussed the pharmacological mechanisms of Qi-replenishing medicines, blood-activating medicines, and their combinations in the prevention and treatment of MIRI. On the basis of the research achievements in the prevention and treatment of MIRI by Qi-replenishing and blood-activating Chinese medicines based on the theory of Qi and blood interacting in vessels, we analyzed the effects of these medicines on Qi, blood, and vessels. According to the theory of Qi and blood, this article reveals the theoretical basis and scientific connotations of the prevention and treatment of cardiovascular diseases, with the aim of providing new ideas and references for the clinical application of traditional Chinese medicine in the prevention and treatment of cardiovascular diseases.  
      关键词:myocardial ischemia-reperfusion injury;Qi and blood interacting in vessels;replenishing Qi and activating blood;mitochondria;platelets;blood vessels   
      15
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74699503 false
      发布时间:2024-11-01
    • 在创伤性颅脑损伤治疗领域,研究团队基于单细胞测序技术揭示了安宫牛黄丸改善损伤的分子机制,为临床治疗提供了新方案。
      YIN Zhiru,TIAN Liangliang,CAO Guangzhao,ZHANG Jingjing,YANG Hongjun
      Vol. 30, Issue 23, Pages: 35-45(2024) DOI: 10.13422/j.cnki.syfjx.20250568
      摘要:ObjectiveTo reveal the molecular mechanism of Angong Niuhuangwan(AGNH) in improving traumatic brain injury(TBI) based on single cell sequencing.MethodSeventy-five male SD rats were randomly divided into the sham group, model group, piracetam group(3.6 g·kg-1), AGNH low- and high-dose groups(0.09, 0.27 g·kg-1), with 15 rats in each group. In addition to the sham group, the other 4 groups used the modified Feeney free-fall impact method to prepare TBI model, and the drugs were administered by gavage immediately after modeling, 24 hours later, the modified neurological deficit score(mNSS) was performed, and brain tissue was isolated to determine the degree of cerebral edema. Hematoxylin-eosin(HE) staining was used to observe the injury degree in the cortex, CA1 region and CA3 region of brain tissue. The expression levels of cyclooxygenase-2(COX-2), interferon regulatory factor 1(IRF1), Janus kinase 2(JAK2) and suppressor of cytokine signaling 3(SOCS3) were observed by immunofluorescence(IF) staining. The levels of interleukin(IL)-6, IL-18, IL-1β, IL-17A, tumor necrosis factor-α(TNF-α), Caspase-1 and nucleotide binding oligomerization domain(NOD)-like receptor heat protein domain associated protein 3(NLRP3) inflammasome were determined by enzyme-linked immunosorbent assay(ELISA). The regulation of AGNH on each cell population was analyzed by single cell sequencing, and differentially expressed genes were analyzed by Gene Ontology(GO) and Kyoto Encyclopedia of Genes and Genomes(KEGG), which led to construct microglia differentially expressed gene network to search for the key targets, and validated by ELISA and IF.ResultCompared with the sham group, the mNSS and brain water content were significantly increased in the model group(P<0.01). Compared with the model group, mNSS and brain water content in the low and high dose AGNH groups were decreased(P<0.05,P<0.01). HE staining results showed that compared with the sham group, the cells in the cerebral cortex and hippocampus of rats in the model group were seriously lost, and the cells were arranged loosely(P<0.01). Compared with the model group, AGNH could significantly increase the density of neurons in the CA1 and CA3 regions of the cerebral cortex and hippocampus, making the arrangement more compact, as well as improved cell morphology(P<0.05,P<0.01). ELISA and IF staining showed that AGNH could reduce the levels of Caspase-1, IL-17A, TNF-α, NLRP3 and COX-2 in brain tissue of TBI rats(P<0.05, P<0.01). A total of 13 cell subsets were identified by single cell sequencing, among which microglia played an important role in neuroimmunity. The results of GO enrichment analysis of differentially expressed genes in microglia showed that AGNH improved TBI in response to inflammation and TNF-α. KEGG enriched IL-17 signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, etc. The results of network analysis showed that the key targets of AGNH in regulating TBI might be IL-6, IL-1β, JAK2, SOCS3, IRF1. IF and ELISA verification results showed that compared with the sham group, SOCS3 expression in microglia was decreased in the model group, and the expressions of IL-6, IL-1β, JAK2 and IRF1 were increased(P<0.01). Compared with the model group, AGNH could increase the expression of SOCS3, decrease the expression of IL-6, IL-1β, JAK2, IRF1 (P<0.05, P<0.01).ConclusionAGNH can reduce the degree of brain edema and brain injury, decrease the expression of inflammatory factors, and inhibit the expression of NLRP3 and its downstream Caspase-1 in TBI rats, which may act on the targets of IL-6, IL-1β, JAK2, IRF1 and SOCS3 in microglia.  
      关键词:Angong Niuhuangwan;traumatic brain injury;single cell sequencing;inflammatory response;microglia;traditional Chinese medicine   
      14
      |
      15
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74698144 false
      发布时间:2024-11-01
    • 最新研究发现,双参苓颗粒能显著改善慢性肾衰竭大鼠肾脏功能及病理损伤,其机制可能与上调PINK1介导的自噬有关。
      LI Shuran,LI Yanying,ZHANG Jingsheng,ZHAO Ronghua,GUO Shanshan,SUN Qiyue,GENG Zihan,BAO Lei,GAO Shuangrong,CUI Xiaolan,SUN Jing
      Vol. 30, Issue 23, Pages: 46-55(2024) DOI: 10.13422/j.cnki.syfjx.20250394
      摘要:ObjectiveTo investigate the pharmacological action and mechanism of Shuangshenling granules in treating chronic renal failure in rats,providing laboratory data to support clinical application of Shuangshenling granules.MethodSD rats (150-180 g),half males and half females in number,were used,with ten rats designated as the normal group,ten as the sham operation group,and the remaining rats undergoing chronic renal failure modeling induced by 5/6 nephrectomy. Two weeks after operation,serum creatinine (SCr) and blood urea nitrogen (BUN) levels were measured via orbital blood sampling to select successful model rats. Based on SCr values,the rats were evenly divided into the model group,Shenshuaining positive group (0.84 g·kg-1·d-1),and high,medium,and low dose groups of Shuangshenling granules (4.8,2.4,1.2 g·kg-1·d-1),with ten animals in each group. Each treatment group received drugs at 10 mL·kg-1 via intragastric administration once daily for six weeks. At 2,4,6 weeks after administration,SCr,BUN,24-hour urine volume,total urinary protein (UTP),urinary creatinine (UCr),creatinine clearance rate (CCr),serum albumin (SAlb),and total serum protein (STP) were measured. Following the experiment,kidney tissues were dissected for pathological examination. The expression levels of autophagy-related proteins,including PTEN-induced kinase 1 (PINK1),E3 ubiquitin-protein ligase parkin (Parkin),and microtubule-associated protein 1 light chain 3B (LC3B),were detected by immunofluorescence.ResultCompared with the normal group,the model group exhibited significantly increased levels of SCr,BUN,24-hour urine volume,UTP,and UCr (P<0.01),and decreased levels of SAlb and STP (P<0.01). CCr showed an initial increase followed by a decrease. Histopathological results revealed glomerular hyperplasia and atrophy,with varying degrees of mesangial cell reduction,blood stasis in the glomeruli,and significant widening of Bowman's capsule. Visceral parietal layer cells were displaced or absent,leading to incomplete and damaged glomeruli. A large number of protein casts were present in the proximal and distal convoluted tubules,with reduced and displaced cells,swelling in some tubules,and interstitial inflammatory exudation predominantly comprising lymphocytes and a small number of neutrophils. Compared with the model group,all dose groups of Shuangshenling granules significantly reduced levels of SCr,BUN,24-hour urine volume,UTP,and UCr (P<0.05,P<0.01) and increased SAlb and STP levels (P<0.01) at 2,4,and 6 weeks after administration. The three dose groups also improved CCr and alleviated renal pathological injury in varying degrees at 2-6 weeks after administration. Immunofluorescence results showed that the expression levels of PINK1,Parkin,and LC3B were significantly reduced in the model group compared with the normal group,whereas all dose groups of Shuangshenling granules significantly upregulated the expression levels of PINK1,Parkin,and LC3B compared with the model group.ConclusionShuangshenling granules significantly improved renal function and pathological injury in rats with chronic renal failure,likely through the upregulation of PINK1-mediated autophagy.  
      关键词:Shuangshenling Granules;chronic kidney failure;serum creatinine;autophagy;5/6 nephrectomy   
      17
      |
      21
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74685991 false
      发布时间:2024-11-01
    • 最新研究发现,白芍总苷能显著减轻马钱子水提物引起的小鼠神经损伤,可能通过调节GRIN2A/PLCB1/PRKCG信号通路发挥作用。
      LI Siyu,YANG Kun,SONG Changyue,CHEN Peiping,ZHANG Xinzhuo,QI Mingzhu,SU Xiaohui,KONG Xiangying
      Vol. 30, Issue 23, Pages: 56-63(2024) DOI: 10.13422/j.cnki.syfjx.20250395
      摘要:ObjectiveTo investigate the effect of total glucosides of paeony (TGP) on neurotoxicity induced by aqueous extract of Strychni Semen (SA) in mice and to explore its mechanism.MethodThirty-two male KM mice were randomly divided into normal group,SA group (19.5 mg·kg-1),TGP group (225 mg·kg-1),and SA+TGP group (SA 19.5 mg·kg-1+TGP 225 mg·kg-1). The open field test and beam walking test were used to observe the behavioral changes in mice. Pathological changes in the Nissl bodies of the cerebral cortex were assessed through Nissl staining. The levels of malondialdehyde (MDA),glutamate (Glu) in the mouse brain tissue,and serum levels of 5-hydroxytryptamine (5-HT) were detected using enzyme-linked immunosorbent assay (ELISA). Transcriptome sequencing was employed to analyze gene expression profiles in the brain tissue. Common differentially expressed genes (DEGs) underwent gene ontology (GO) and kyoto encyclopedia of genes and genomes (KEGG) enrichment analyses. The mRNA expression levels of key targets were determined using quantitative real-time polymerase chain reaction (Real-time PCR).ResultCompared with the normal group,the SA group exhibited significant increases in side-to-side distance and average speed in the open field test,as well as increased walking time on the balance beam. The axons of cortical neurons were absent,and the levels of Glu and MDA in the brain tissue were significantly elevated (P<0.05,P<0.01),along with a notable increase in serum 5-HT levels (P<0.05). In contrast to the SA group,the SA+TGP group significantly reduced the side-to-side distance,average speed,and balance beam walking time (P<0.05 or P<0.01). The neuronal axons were clearly visible,and levels of 5-HT,Glu,and MDA were decreased (P<0.05,P<0.01). Transcriptome analysis indicated that TGP could regulate the glutamate receptor,ionotropic,N-methyl-D-aspartate 2a (GRIN2A)/phospholipase C β1 (PLCB1)/protein kinase C,gamma (PRKCG) signaling pathway. Compared with the normal group,SA significantly decreased the expression of GRIN2A,PLCB1,and PRKCG genes in the mouse brain (P<0.01),while the mRNA levels of GRIN2A and PRKCG significantly increased after TGP administration (P<0.05,P<0.01).ConclusionSA induces significant neurotoxicity in the mouse brain,and TGP significantly alleviates SA-induced neurological damage,potentially through the GRIN2A/PLCB1/PRKCG signaling pathway.  
      关键词:aqueous extract of Strychni Semen;total glucosides of paeony;neurotoxicity;formulation to reduce toxicity;glutamate receptor,ionotropic, N-methyl-D-aspartate 2a (GRIN2A)/phospholipase C β1 (PLCB1)/protein kinase C, gamma (PRKCG) signaling pathway   
      16
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74686033 false
      发布时间:2024-11-01
    • 最新研究揭示中药导致胆汁淤积型肝损伤特点,主要集中在清热药,核心靶点为ABCG2、IFN-γ等,调控途径涉及转运体、微血管功能调节等。
      YANG Yun,ZHANG Guozhuang,LIU Ting,YANG Yifei
      Vol. 30, Issue 23, Pages: 64-71(2024) DOI: 10.13422/j.cnki.syfjx.20241512
      摘要:ObjectiveTo explore the characteristics and regulatory mechanisms of cholestatic liver injury (CLI) caused by traditional Chinese medicine based on data mining, network pharmacology, and molecular docking.MethodChina National Knowledge Infrastructure and PubMed were searched for the relevant literature on CLI caused by traditional Chinese medicine from inception to 2024, and the information was standardized, summarized, and analyzed by cluster analysis. The Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), Integrative Pharmacology-based Research Platform of Traditional Chinese Medicine (TCMIP), GeneCards, Online Mendelian Inheritance in Man (OMIM), and DisGeNET were used to retrieve the active ingredients and targets of core medicines. The Venn diagram was established to map the common targets shared by the core medicines and CLI. Cytoscape 3.10.2 was used to construct the protein-protein interaction (PPI) network of the common targets. DAVID was used for gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment of the core targets. Finally, molecular docking was performed by AutoDock Vina.ResultA total of 849 eligible articles were included in this study, from which 64 active ingredients of 39 herbal medicines that can cause cholestasis were counted and categorized according to the 2020 edition of the Pharmacopoeia of the People's Republic of China. The frequency of the medidicnes followed a descending order of heat-clearing medicines, exterior-releasing medicines, blood-activating and stasis-resolving medicines, purgative medicines, phlegm-resolving and cough- and dyspnea-relieving medicines, tonics, wind- and dampness-expelling medicines, interior-warming medicines, urination-promoting and dampness-draining medicines, Qi movement-regulating medicines, hemostatics, toxin-removing, worm-killing, and itch-relieving medicines, astringent medicines, dampness-eliminating medicines, and tranquiling medicines. The cluster analysis revealed that the reports of CLI caused by heat-clearing medicines accounted for the highest proportion of 39.69%. Among the heat-clearing medicines, Gardeniae Fructus (92 articles, accounting for 10.84%), Scutellariae Radix (76 articles, 8.95%), and Sophorae Flavescentis Radix (69 articles, 6.95%) were frequently reported. The core targets of cholestasis induced by Chinese herbal medicines reported to cause CLI mainly included tumor necrosis factor (TNF), peroxisome proliferator activated receptor alpha (PPARA), farnesoid X receptor (FXR), glutamic-pyruvic transaminase 2 (GPT2), superoxide dismutase 1 (SOD1), interferon gamma (IFN-γ), interleukin-6(IL-6), CD36, Apolipoprotein A1(APOA1), Angiotensin converting enzyme(ACE), Cytochrome P450 3A4 enzyme(CYP3A4), Protein kinase B1(Akt1), APOB, albumin(ALB), ATP binding cassette transporter A4(ABCB4), SLC10A1, Estrogen Receptor alpha (ESR1), signal transducer and activator of transcription1(STAT1), β-actin(ACTB), Endothelin 1(EDN1), ABCG2, and peroxisome proliferator activated receptor gamma(PPARG). The signaling pathways involved included bile secretion, ABC transporter, steroid biosynthesis, DNA adducts, drug metabolism, cytochrome P450, peroxisomes, primary bile acid biosynthesis, retinol metabolism, and Toll-like receptor. The molecular docking results showed that the active ingredients (e.g., baicalin and berberine) of the heat-clearing medicines reported by high frequency to cause CLI had high binding affinity to the targets including ABCG2, IFN-γ, EDN1, IL-6 and SOD1, with the binding energy in the range of -13 kcal·mol-1 to -9 kcal·mol-1, and the regulatory pathways were highly correlated with transporters, microvascular function regulation, inflammation, and oxidative stress, which was consistent with the cluster analysis.ConclusionThe available reports about the Chinese herbal medicines causing CLI mainly focused on heat-clearing medicines, and the core targets included ABCG2, IFN-γ, EDN1, IL-6, and SOD1. The regulatory pathways were mainly related to transporters, microvascular function regulation, inflammation, and oxidative stress.  
      关键词:Chinese herbal medicine;cholestasis;molecular docking;network toxicology;regulatory mechanisms   
      12
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74704500 false
      发布时间:2024-11-01
    • 最新研究利用中药毒性预警体系预测保健食品潜在肾损伤成分,并通过实验验证,为中药安全性研究提供新思路。
      LI Han,SONG Ling,GAO Yunhang,CHEN Tengfei,MU Suzhen,CHEN Weiya,ZHANG Guangping,HUO Wang
      Vol. 30, Issue 23, Pages: 72-80(2024) DOI: 10.13422/j.cnki.syfjx.20241102
      摘要:ObjectiveTo predict the potential nephrotoxic components in traditional Chinese medicine health food products based on the Traditional Chinese Medicine Toxicity Alert System and Basic Toxicology Database (TCMTAS-BTD), screen and validate the predicted components by cell and animal experiments, and decipher the mechanism of nephrotoxicity by network pharmacology.MethodTCMTAS-BTD was utilized to predict the toxicity of 3 540 compounds found in the catalogue of traditional Chinese health food ingredients. In the cell experiment, the top 5 compounds with high toxicity probability were screened by measurement of cell proliferation and viability (CCK-8) and high-content screening. ICR mice were randomized into a control group, a low-dose (2.91 mg·kg-1·d-1) ecliptasaponin A, and a high-dose (29.1 mg·kg-1·d-1) ecliptasaponin A group, with 10 mice in each group, and treated continuously for 28 days. During the experiment, the general conditions of the rats were observed, and the kidney index was calculated. The levels of serum creatinine (SCr) and blood urea nitrogen (BUN) in the serum as well as the content of malondialdehyde (MDA) and superoxide dismutase (SOD) in the renal tissue were measured. The pathological changes of the kidney were observed. Network pharmacology was employed to predict the potential pathways of nephrotoxicity. Finally, the pathway-associated proteins were validated by Western blot.ResultThe top 5 compounds with high probability of nephrotoxicity were ecliptasaponin A, chrysophanol, rutaecarpine, tanshinoneⅠ, and geniposidic acid. In the cell experiment, CCK-8 results showed that 10 μmol·L-1 ecliptasaponin A, 60 μmol·L-1 chrysophanol, 40 μmol·L-1 rutaecarpine, and 20 μmol·L-1 tanshinone I altered the viability of HK-2 cells. High-content analysis showed that 10 μmol·L-1 ecliptasaponin A, chrysophanol, rutaecarpine, and tanshinone Ⅰ reduced the cell number (P<0.05, P<0.01). The animal experiment showed that the mice in the high-dose ecliptasaponin A group presented slow movement, slow weight gain (P<0.01), increased kidney index (P<0.01), elevated SCr, BUN, and MDA levels (P<0.01), and lowered SOD level (P<0.01). Mild histopathological changes were observed in the high-dose ecliptasaponin A group. The network pharmacology results showed that the key targets of nephrotoxicity induced by ecliptasaponin A were mainly enriched in the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway, prostatic cancer and lipid and atherosclerosis pathways. Western blot results verified that high dose of ecliptasaponin A raised the phosphorylation levels of PI3K and Akt (P<0.01).ConclusionOn day 28 of administration, 29.1 mg·kg-1 ecliptasaponin A was found to induce renal injury in rats. The mechanism may be related with the PI3K/Akt signaling pathway, which implied that excessive and prolonged usage of Ecliptae Herba may increase the incidence of adverse drug reactions.  
      关键词:nephrotoxicity;computational toxicology;safety of traditional Chinese medicine;ecliptasaponin A;network pharmacology   
      8
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74713044 false
      发布时间:2024-11-01
    • 百里香药茶含有多种抗病毒成分,能有效抑制人冠状病毒OC43复制,为冠状病毒治疗提供新思路。
      TIAN Jixiang,ZHANG Tongtong,CHANG Yuning,XIE Peifang,DONG Shuwei,ZHAO Xiaoang,WANG Yun,ZHAO Chunhui,WU Hongwei,ZHANG Amei,LI Haizhou,XIA Xueshan,ZHANG Huamin
      Vol. 30, Issue 23, Pages: 81-89(2024) DOI: 10.13422/j.cnki.syfjx.20241504
      摘要:ObjectiveTo investigate the effects of thyme herbal tea (BLX) on the proliferation of human coronavirus OC43 (HCoV-OC43) in vitro and in vivo.MethodThe chemical composition of BLX was analyzed by UPLC-MS. The cytotoxicity of BLX in HRT-18 cells and the effect of BLX treatment on the proliferation of HCoV-OC43 in cells were analyzed. Copies of viral gene were detected by real-time PCR. The effect of BLX treatment on the life cycle of HCoV-OC43 was detected by time-of-addition assay. The maximum tolerated dose of BLX and the influences of BLX on the body weight and survival time of suckling mice infected with HCoV-OC43 were determined. The expression of viral protein in the brain and lung tissue was analyzed by immunohistochemistry.ResultThere were 11 chemical components identified in BLX by UPLC-MS. BLX showed the 50% cytotoxic concentration (CC50) of (13 859.56±319) mg·L-1, the median inhibitory concentration (IC50) of (1 439.09±200) mg·L-1, and the selection index of 8.26-11.44 for HCoV-OC43 in HRT-18 cells. Compared with the cells infected with HCoV-OC43, BLX at the concentrations of 1 500, 1 000, 500 mg·L-1 inhibited the proliferation of this virus (P<0.05, P<0.01). BLX exhibited antiviral effect in the early stage of virus infection, and the inhibition role in the attachment stage was more significant than that in the entry stage (P<0.05). In the suckling mice infected with HCoV-OC43, BLX at 1200 and 600 mg·kg-1·d-1 alleviated the symptoms, prolonged the survival period, reduced the death rate, and down-regulated the mRNA level of nucleocapsid protein in the mice. Moreover, BLX at 1 200 mg·kg-1·d-1 down-regulated the expression of nucleocapsid protein in the brain (P<0.01) and the lung (P<0.01).ConclusionBLX contained multiple antiviral ingredients. It inhibited the proliferation of HCoV-OC43 both in vitro and in vivo by interference with viral attachment. This study provides theoretical reference for the treatment of acute respiratory tract infection with HCoV-OC43 and for further development and application of BLX.  
      关键词:thyme herbal tea;human coronavirus OC43 (HCoV-OC43);antiviral activity;cell model;mouse model   
      12
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74718731 false
      发布时间:2024-11-01
    • 疏风解毒胶囊含药血清能有效抑制流感病毒,提高肺上皮细胞存活率,减少细胞凋亡,下调相关蛋白表达,发挥抗流感病毒作用。
      CAO Shan,GENG Zihan,BAO Lei,XU Yingli,PANG Bo,ZHANG Jingsheng,ZHANG Yu,CHEN Mengping,WANG Yaxin,ZHAO Ronghua,GUO Shanshan,CUI Xiaolan
      Vol. 30, Issue 23, Pages: 90-97(2024) DOI: 10.13422/j.cnki.syfjx.20241505
      摘要:ObjectiveTo observe the effect of Shufeng Jiedu capsule (SFJD)-containing serum on human lung epithelial cells infected by influenza A virus, and investigate the protective effect of the drug on the cells and the potential antiviral effect.MethodThe SFJD-containing serum was prepared and used to treat human lung epithelial cells (BEAS-2B) cultured in vitro. The viability of cells treated with different concentrations of SFJD-containing serum was measured by the cell counting kit-8 (CCK-8), and the optimal concentration of SFJD-containing serum was screened for subsequent experiments. BEAS-2B cells were classified into normal control, virus infection, and SFJD-containing serum groups, and the CCK-8 method was used to detect the survival rate of BEAS-2B cells after virus infection and drug administration. The expression of influenza virus nucleic acid in the cells of each group was determined, and the apoptosis of cells in different groups was observed by fluorescence microscopy. Real-time PCR was employed to determine the mRNA levels of influenza virus nucleoprotein (NP), Toll-like receptor 4 (TLR4), and myeloid differentiation primary response gene 88 (MyD88) in each group of cells. The immunofluorescence assay was used to detect the fluorescence intensities of TLR4, MyD88, and phosphorylated nuclear factor-κB (p-NF-κB) in lung epithelial cells.ResultCompared with that in the control group (normal serum), the cell survival rates in the blank serum and the SFJD-containing serum (5%, 10%, and 20%) groups were 100.00%±0.00%, 89.05%±4.80%, 87.13%±5.90%, 93.83%±6.03%, and 99.33%±3.39%, respectively (P<0.01). The SFJD-containing serum of 20% was selected as the optimal treatment for subsequent experiments. Compared with the normal control group, the virus infection group showed reduced cell survival rate (P<0.01), and the reduction was increased by the SFJD-containing serum (P<0.01). Compared with the virus infection group, SFJD-containing serum reduced the virus load (P<0.01) to decrease apoptosis. Compared with the normal control group, the virus infection group showed up-regulated mRNA levels of NP, TLR4, and MyD88 (P<0.01), and the up-regulation was down-regulated by the SFJD-containing serum (P<0.05, P<0.01). The fluorescence intensities of TLR4, MyD88, and p-NF-κB proteins in the cells increased after virus infection compared with those in the normal control (P<0.05, P<0.01), and they were decreased after administration with the SFJD-containing serum (P<0.05).ConclusionThe SFJD-containing serum can inhibit influenza virus in vitro by increasing the survival rate, reducing the apoptosis, and down-regulating the protein levels of TLR4, MyD88, and p-NF-κB in BEAS-2B cells.  
      关键词:influenza A virus;Shufeng Jiedu capsules;BEAS-2B cells;apoptosis   
      14
      |
      21
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74718147 false
      发布时间:2024-11-01
    • 最新研究发现,痰热清注射液能调节COPD模型大鼠肺部菌群多样性和菌属丰富度平衡,为防治COPD提供新机制。
      LUO Qian,FU Rui,PENG Bo,CHEN Weiya,WEI Xiaolu,CHEN Tengfei,SONG Ling,GAO Yunhang,ZHANG Guangping,HOU Hongping
      Vol. 30, Issue 23, Pages: 98-103(2024) DOI: 10.13422/j.cnki.syfjx.20240907
      摘要:ObjectiveTo study the effect of Tanreqing injection (TRQ) on the pulmonary flora in the rat model of chronic obstructive pulmonary disease (COPD).MethodWistar rats were randomized into control, model, and TRQ groups. The rats in other groups except the control group were treated by smoking combined with intratracheal instillation of lipopolysaccharide for the modeling of COPD. The TRQ group was intraperitoneally injected with TRQ (2 g·kg-1). At the end of the experiment, after blood collection from the abdominal aorta of the rats, the lung tissue was collected for hematoxylin-eosin and picric sirius red staining to reveal the pathological changes. The lung lavage fluid was collected, and the diversity and relative abundance of lung flora in different groups were analyzed by 16S rDNA amplicon sequencing.ResultThe lungs of the control group were normal, and those of the model group showed neutrophil infiltration, telangiectasia, lung hemorrhage and emphysema in individual cases, and thickening of collagen fibers in the trachea. Compared with the model group, the TRQ group showed significantly improved lungs and recovered collagen fibers. The MLI analysis showed that compared with the control group, the model group showcased increased alveolar space (P<0.01), which was reduced in the TRQ group (P<0.05). Compared with the control group, the model group showed increased wall thickness (P<0.01), and the increase was attenuated in the TRQ group (P<0.01). TRQ increased the Simpson index and altered the α diversity of pulmonary flora. The results of principal co-ordinate analysis showed that TRQ changed the β diversity and reduced the β diversity index of pulmonary flora. At the genus level, the model group showed increased relative abundance of g_Bacillus and g_Brevundimonas and decreased relative abundance of g_Pseudomonas, compared with the control group. After treatment with TRQ, the relative abundance of g_Stenotrophomonas increased, and that of g_Bacillus decreased. The LEfSe of differential taxa between groups showed that the modeling increased the relative abundance of g_Lachnospiraceae_NK4A136_group, and TRQ treatment increased the relative abundance of g_Rhodococcus and g_Stenotrophomonas.ConclusionTRQ can regulate the diversity of pulmonary flora and restore the balance of bacterial genera in the rat model of COPD, which may be one of the mechanisms of the prevention and treatment of COPD with TRQ.  
      关键词:Tanreqing injection;chronic obstructive pulmonary disease (COPD);lung lavage fluid;pulmonary flora;microbial diversity   
      16
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74718835 false
      发布时间:2024-11-01
    • 最新研究发现,菖菊止动方能有效调节抽动障碍患儿肠道菌群结构,改善核心症状和胃肠症状,提高有益菌丰度,降低有害菌丰度,可能通过萜类和聚酮类代谢发挥作用。
      ZHANG Qiang,LIU Tuo,WANG Junhong,YAN Yurou,SUN Ting,LIU Chengcheng
      Vol. 30, Issue 23, Pages: 104-110(2024) DOI: 10.13422/j.cnki.syfjx.20250566
      摘要:ObjectiveTo investigate the regulatory effect of Changju Zhidong prescription on gut microbiota structure of children with tic disorder(TD).MethodTwenty-four children with TD who visited the pediatric outpatient clinic of Dongzhimen Hospital of Bejjing University of Chinese Medicine from November 2020 to January 2022 were selected as the observation group, and eight healthy children were selected as the normal group. The observation group was treated with Changju Zhidong prescription for 12 weeks, and the clinical efficacy was observed by Yale global tic severity scale(YGTSS), traditional Chinese medicine(TCM) syndrome score, and score of TCM symptom evaluation scale for pediatric gastrointestinal tract. Meanwhile, The fecal samples of the observation and normal groups were collected before and after treatment, and 16S rDNA sequencing was used to explore the effects of Changju Zhidong prescription on the distribution of gut microbiota of the children.ResultCompared with the pre-treatment, the YGTSS, TCM syndrome score, and score of TCM symptom evaluation scale for pediatric gastrointestinal tract of the observation group were significantly reduced after 12 weeks of treatment(P<0.05), Simpson and Pieloue indices in alpha diversity were significantly reduced(P<0.05). Before treatment, the relative abundance of Streptococcus parasanguini in the observation group was significantly higher than that of the normal group, while the relative abundances of Citrobacter, Lactobacillus, Lacticaseibacillus, Muribaculaceae unclassified, Odoribacter and 7 other bacterial groups were significantly lower than that in the normal group. Compared with the pre-treatment, the observation group showed a significant decrease in Ruminococcus torques group unclassified and Ruminococcus torques group, and a significant increase in Olsenella, Acetivibrio and 4 other bacterial groups. Functional enrichment analysis showed that the main pathways of Changju Zhidong prescription regulating gut microbiota were bacterial secretion system, insect hormone biosynthesis, limonene and pinene degradation, novobiocin biosynthesis, tropane piperidine and pyridine alkaloid biosynthesis.ConclusionThe pathogenesis of children with TD is accompanied by intestinal flora disorders, and Changju Zhidong prescription can improve core and gastrointestinal symptoms, increase the abundance of beneficial and decrease the abundance of harmful gut microbiota in children with TD, and its mechanism may be through the metabolism of terpenoids and polyketides.  
      关键词:tic disordor;intestinal flora;Changju Zhidong prescription;pediatrics;traditional Chinese medicine;clinical pharmacology   
      17
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74698113 false
      发布时间:2024-11-01
    • 最新研究发现,三七总皂苷能抑制高剪切诱导的Piezo1介导的钙离子内流,改善血小板聚集和动脉血栓形成。
      WANG Yilin,LI jia,LIU Lu,GONG Ping,XU Jing,LIAO Fulong,YOU Yun
      Vol. 30, Issue 23, Pages: 111-120(2024) DOI: 10.13422/j.cnki.syfjx.20241018
      摘要:ObjectiveTo investigate the mechanisms of Panax notoginseng saponins (PNS) in inhibiting high shear-induced platelet aggregation and thrombosis via the Piezo1-mediated calcium signaling pathway.MethodBioflux1000z was used for the microfluidic assay, where platelets were stimulated with physiological shear rate (500 s-1), pathological shear rate (12 000 s-1), or Piezo1 agonist Yoda1 under the physiological shear rate (500 s-1). The shear-induced platelet calcium influx and the binding of platelet with von Willebrand factor (vWF) were measured by flow cytometry. Enzyme-linked immunosorbent assay (ELISA) was employed to measure the vWF release from platelets. The microfluidic channels were used to determine the vWF-mediated platelet aggregation and integrin αⅡbβ3 activation. A mouse model of arterial thrombosis induced by high shear stress combined with endothelial injury was established. The ultrasonic Doppler flow meter was used to monitor the cyclic flow reduction (CFR) caused by the repeated formation and shedding of thrombi, and flow cytometry was employed to examine platelet-vWF binding, on the basis of which the effect of PNS on high shear-induced arterial thrombosis was evaluated.ResultThe microfluidic assay showed that PNS decreased the high shear rate (12 000 s-1) or Yoda1-induced calcium influx, platelet-vWF binding, vWF-mediated platelet-fibrinogen binding, and vWF release from platelet alpha-granules in a dose-dependent manner. In the mouse model of high shear-induced thrombosis, PNS markedly reduced the CFR and occlusion time of the common carotid artery and inhibited platelet-vWF binding.ConclusionPNS can mitigate pathological shear-induced platelet aggregation and arterial thrombosis via influencing Piezo1/GPIbα-vWF signaling.  
      关键词:arterial thrombosis;shear stress;platelet;Piezo1;von Willebrand factor (vWF);Panax notoginseng saponins   
      14
      |
      16
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74704343 false
      发布时间:2024-11-01
    • 最新研究发现,丹红注射液治疗慢性稳定型心绞痛疗效驱动机制,为临床治疗提供科学依据。
      TIAN Siwei,ZONG Wenjing,LIU Jun,YANG Wei,NIU Qikai,ZHANG Siqi,WANG Jing'ai,ZHANG Huamin,WANG Zhong,LI Bing
      Vol. 30, Issue 23, Pages: 121-128(2024) DOI: 10.13422/j.cnki.syfjx.20241515
      摘要:ObjectiveTo explore the efficacy-driving mechanism of Danhong injection (DHI) in the treatment of stable angina pectoris (SAP) based on the composition-activity relationship of target modules and clarify the pharmacological effects of DHI.MethodAccording to the angina frequency (AF) in the Seattle Angina Questionnaire (SAQ) that was obtained in the previous clinical trial, the patients before and after DHI treatment were grouped based on efficacy. The transcriptomic data of the patients before treatment and in the best efficacy group 30 days post-treatment were selected as the data source, and then weighted gene co-expression network analysis (WGCNA) was employed to construct the co-expression network. Relevant modules in the network were identified and associated with clinical features. In addition, the On-modules (Z value below 0) were identified by Zsummary. The topological indicators such as density, centrality, and clustering coefficient were adopted to explore the dynamics of DHI efficacy at the network level and module level, respectively. In addition, the driver genes were screened by the personalized network control (PNC) algorithm. Finally, rat H9C2 cells were used to establish the model of hypoxia/reoxygenation (H/R), which was used to confirm the potential therapeutic target of DHI for SAP and provide a scientific basis for revealing the therapeutic mechanism of DHI.ResultWe identified 19 modules in the best efficacy group of DHI for SAP, and the comparison between day 0 and day 30 revealed 12 On-modules. The changes of network topological indicators at the network and module levels confirmed the correlation between the best efficacy of DHI treatment and topological dynamics. Finally, the driver genes, Klotho and fibroblast growth factor 22 (FGF22), in DHI treatment of SAP were verified by the H9C2 cell model of H/R.ConclusionBased on clinical transcriptome data, this study determined the composition-activity relationship of target modules of DHI for SAP, which provided a scientific basis for deciphering the efficacy-driven mechanism of DHI for SAP.  
      关键词:target module;efficacy driven;Danhong injection;mechanism   
      14
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74704468 false
      发布时间:2024-11-01
    • 最新研究发现,番红花去柱头花部替代车前子后的痛风舒颗粒新方,在治疗高尿酸血症合并痛风性关节炎方面具有同等效果,为中药新资源研究提供新策略。
      WU Jiping,LI Qingqing,WANG Lan,YIN Xiaojie,FENG Shuyi,WANG Zhihao,LIANG Rixin,YANG Bin,LI Zhiyong
      Vol. 30, Issue 23, Pages: 129-140(2024) DOI: 10.13422/j.cnki.syfjx.20250565
      摘要:ObjectiveTo investigate the efficacy and mechanism of saffron floral bio-residues(SFB) in the treatment of hyperuricemia(HUA) combined with gouty arthritis(GA) in a compound compatibility setting.MethodScreening candidate control Chinese medicines for compound and SFB based on network target distance calculation and data analysis. After adaptive feeding of 80 SD rats for 7 days, 10 rats were randomly selected as the blank group, while the remaining 70 rats were intraperitoneally injected with 3% potassium oxonate and orally administered with 1% adenine for 14 consecutive days. On the 13th day, rats were injected with 2.5% sodium urate solution into the right ankle joint cavity to induce swelling of the joint capsule on the opposite side, inducing a HUA combined with GA model. At the same time, the modeling rats were randomly divided into 7 groups, including the model group, benzbromarone group(positive drug, 0.02 g·kg-1), Tongfengshu tablets group(9 g·kg-1), Tongfengshu granules group(9 g·kg-1), SFB granules group(3.6 g·kg-1), Plantaginis Semen granules group(3.6 g·kg-1), and new formula group(SFB replacing Plantaginis Semen in Tongfengshu granules, 9 g·kg-1), with 10 rats in each group. Each treatment group was orally administered with the corresponding drugs according to body weight, while the control and model groups were given equal volume of distilled water by gavage once a day for 14 consecutive days. After 14 days of synchronous administration and modeling, changes in gait, ankle joint swelling and mechanical pain threshold in rats were observed, and serum uric acid, creatinine, urea nitrogen and xanthine oxidase(XOD) were measured. Enzyme-linked immunosorbent assay(ELSIA) was used to detect the levels of tumor necrosis factor(TNF)-α, interleukin(IL)-1β and IL-6 in rat serum, hematoxylin-eosin(HE) staining was used to observe the pathological changes in the liver, kidney and ankle joints of rats, Western blot was used to detect the expression levels of uric acid transporter 1(URAT1), glucose transporter 9 (GLUT9), organic anion transporter 1(OAT1), adenosine triphosphate(ATP) binding cassette transporter G2(ABCG2), and liver XOD proteins.ResultThrough network pharmacology analysis, Plantaginis Semen was selected as a candidate control herb, and Tongfengshu tablets was used as a compound compatibility environment to explore the efficacy of SFB in reducing blood uric acid levels and treating GA. Animal experiments showed that compared with the blank group, the gait score and joint swelling degree of the model group were significantly increased, and the mechanical pain threshold was significantly decreased(P<0.01). Compared with the model group, the gait score, joint swelling degree and mechanical pain threshold of rats in each medication group were improved to varying degrees. Biochemical indicators showed that compared with the blank group, the serum uric acid, creatinine, urea nitrogen and XOD levels of the model group were significantly increased(P<0.01). Compared with the model group, the serum uric acid and XOD levels of rats in each treatment group were significantly decreased(P<0.01). ELISA results showed that compared with the blank group, the levels of serum TNF-α, IL-1β and IL-6 in the model group were significantly increased(P<0.01). Compared with the model group, the levels of TNF-α, IL-1β and IL-6 in the benzbromarone group, Tongfengshu tablets group, Tongfengshu granules group and new formula group were significantly reduced(P<0.05,P<0.01). Western blot results showed that compared with the blank group, the expression levels of URAT1 and GLUT9 proteins in renal tissue and OXD protein in liver tissue of the model group were significantly increased, while the expression levels of renal OAT1 and ABCG2 were significantly decreased(P<0.01). Compared with the model group, the expression levels of renal URAT1 and GLUT9 in the SFB granules group, Tongfengshu granules group and new formula group were significantly decreased, while the expression levels of renal OAT1 and ABCG2 were significantly increased, and the expression of XOD protein in liver tissue was significantly decreased(P<0.05, P<0.01). Pathological analysis showed that focal infiltration of neutrophils, cell necrosis and nuclear fragmentation were observed in the liver tissue of the model group, sodium urate deposition crystals and tubular dilation appeared in renal tissue, synovial hyperplasia and inflammatory cell infiltration appeared in ankle joint. Compared with the model group, the abnormal degrees of liver, kidney and ankle joint tissue of rats in each treatment group were alleviated.ConclusionThe new formula of SFB replacing Plantaginis Semen has the same effect in the treatment of HUA combined with GA. This study proposes a new strategy to investigate the efficacy of new resources of Chinese medicine in a compound compatibility environment, which can provide a new demonstration for the research and development of new resources of Chinese medicine.  
      关键词:new resources of Chinese medicine;Saffron Floral bio-residues;hyperuricemia;gouty arthritis;compound compatibility;network pharmacology   
      20
      |
      20
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74685948 false
      发布时间:2024-10-15
    • 最新研究发现,脑心通胶囊能改善脑及肠道屏障损伤,调节短链脂肪酸含量,发挥脑缺血再灌注保护作用。
      ZHANG Jing,LI Yu,LEI Yuxin,CHANG Mengli,WANG Yanan,XU Jing,TANG Shihuan
      Vol. 30, Issue 23, Pages: 141-148(2024) DOI: 10.13422/j.cnki.syfjx.20241507
      摘要:ObjectiveTo explore the mechanism of Naoxintong capsules' intervention in cerebral ischemia-reperfusion by building a mouse cerebral ischemia-reperfusion model based on short-chain fatty acids.MethodC57BL/6J male mice were randomly divided into the sham group, model group, Naoxintong group (158.9 mg∙kg-1), and Ginaton group (12.1 mg∙kg-1) according to the random number table method. The model of cerebral ischemia-reperfusion (MCAO/R) was prepared via the filament occlusion method. The effect of Naoxintong capsules on brain injury in MCAO/R mice was evaluated by the neuroethological score, cerebral infarction area determination, Nissl staining, and immunofluorescence staining. Hematoxylin-eosin (HE) staining and Western blot were employed to evaluate the effect of Naoxintong capsules on the intestinal barrier in MCAO/R mice. The content of short-chain fatty acids in mouse feces was detected by LC-MS/MS.ResultCompared to the sham group, the model group exhibited significant increases in the cerebral infarction area, neuroethological score, and cell apoptosis rate (P<0.01), with a notable decrease in the number of Nissl bodies (P<0.01). The protein expression levels of Claudin-1 and Occludin were significantly reduced (P<0.05). Compared with the model group, the intervention of Naoxintong capsules significantly decreased the cerebral infarction area (P<0.05) and improved the neuroethological score (P<0.01) and cell apoptosis rate (P<0.01), with the number of Nissl bodies (P<0.01) and expression levels of Claudin-1 and Occludin proteins (P<0.01) increased. LC-MS/MS results showed that compared to the sham group, the model group featured a significantly reduced content of acetic acid, propionic acid, and butyric acid in feces (P<0.01), while valeric acid, isovaleric acid, and isobutyric acid levels were increased (P<0.01). The intervention of Naoxintong capsules notably lowered the content of valeric acid, isovaleric acid, and isobutyric acid (P<0.01).ConclusionNaoxintong capsules can improve brain and intestinal barrier damage and play a protective role in cerebral ischemia-reperfusion by regulating the content of short-chain fatty acids.  
      关键词:cerebral ischemia-reperfusion injury;intestinal barrier;Naoxintong capsules;short-chain fatty acids;LC-MS/MS   
      6
      |
      17
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 76306151 false
      发布时间:2024-11-01
    • 在慢性冠脉综合征治疗领域,多中心前瞻性队列研究显示,通心络胶囊能显著减少气虚血瘀型患者抗缺血药物使用。
      ZHANG Chenhao,WANG Jia,LIU Yiying,YANG Xiaohe,WANG Xuesen,GAO Meili,DONG Yu,LI Xiaotao
      Vol. 30, Issue 23, Pages: 149-156(2024) DOI: 10.13422/j.cnki.syfjx.20250392
      摘要:ObjectiveTo investigate the effect of Tongxinluo capsules on the use of anti-ischemic drugs in patients with chronic coronary syndrome (CCS) of Qi deficiency and blood stasis.MethodA multicenter,prospective cohort study was conducted,with Tongxinluo capsules intervention as the exposure factor. Patients were divided into an exposed group (combination of traditional Chinese and western medicine) and a non-exposed group (western medicine alone),and followed up for one year. The use of anti-ischemic drugs was observed on the day of enrollment and at 3,6,12 months.ResultA total of 186 patients were enrolled,with 128 in the exposed group and 58 in the non-exposed group. There were no statistically significant differences in baseline characteristics between the two groups. At the 3-month follow-up,the types of first-line anti-ischemic drugs used in the exposed group were significantly fewer than those in the non-exposed group (P<0.01),and this difference remained statistically significant at 6 months (P<0.05) but was no longer significant at 12 months. At the 3- and 6-month follow-ups,there were no significant differences between the two groups in the types of second-line anti-ischemic drugs used. However,at the 12-month follow-up,the types of second-line anti-ischemic drugs used in the exposed group were significantly fewer than those in the non-exposed group (P<0.01). At the 3-month follow-up,both groups showed a reduction in the types of first-line anti-ischemic drugs used compared to baseline (P<0.05),with a more pronounced reduction in the exposed group (P<0.05). At the 6-month follow-up,the exposed group showed a significant reduction in the types of second-line anti-ischemic drugs used compared to baseline (P<0.05),while no significant changes were observed in the non-exposed group. At the 12-month follow-up,the difference in the types of second-line anti-ischemic drugs between the exposed and non-exposed groups was statistically significant (P<0.05),while there was no significant difference in the types of first-line anti-ischemic drugs.ConclusionTongxinluo capsules can effectively reduce the use of anti-ischemic drugs in patients with CCS of Qi deficiency and blood stasis.  
      关键词:Tongxinluo Capsules;Qi deficiency and blood stasis type;chronic coronary syndrome;anti-ischemic drugs;prospective cohort study   
      18
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74686124 false
      发布时间:2024-11-01
    • 最新研究发现,黄芩汤能有效干预结直肠癌发展,通过调节肠道菌群结构,延缓结肠炎癌转化。
      ZHU Lin,WANG Dunfang,FENG Xue,ZHANG Caijuan,LIU Haifan,LIU Yaqing,LIU Bin,LIU Li,CHEN Siyuan,YANG Weipeng
      Vol. 30, Issue 23, Pages: 157-169(2024) DOI: 10.13422/j.cnki.syfjx.20242130
      摘要:ObjectiveTo construct a mouse model of inflammation-associated colorectal cancer (CAC) by using azoxymethane (AOM)/dextran sulfate sodium (DSS) and investigate the effect of Huangqintang on the gut microbiota structure of mice during the occurrence and development of CAC by 16S rRNA gene high-throughput sequencing.MethodA total of 225 C57BL/6J mice were randomized into 5 groups (n=45): Normal, model, positive drug (mesalazine), and high (18 g·kg-1) and low (9 g·kg-1)-dose Huangqintang. Except those in the normal group, each mouse was injected with 10 mg·kg-1 AOM on day 1 and day 5 within 1 week and then given 1.5% DSS solution for 7 days, which was then changed to sterile water for 14 days. This process referred to as one cycle, and mice were treated for a total of 3 cycles. On the first day of DSS treatment, mice were administrated with corresponding drugs by gavage, and the normal group and the model group were administrated with pure water by gavage, once a day until the end of the third cycle. The progression of CAC was divided into inflammation, proliferation, and tumorigenesis stages. At the end of each cycle, the body weight and colon length were measured for mice in each group, and the number of colon tumors in mice was recorded. Meanwhile, the disease activity index (DAI) was determined. The serum levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and carbohydrate antigen-199 (CA199), a tumor marker in the gastrointestinal tract of mice, were measured by ELISA. Hematoxylin-eosin staining was employed to observe colon lesions. At the same time, 3-5 pellets of fresh feces of mice in the normal group, model group, and high-dose Huangqintang group were collected, from which the fecal DNA of mice was extracted for 16S rRNA gene high-throughput sequencing.ResultCompared with the normal group, the model group showed decreased body weight (P<0.01), increased DAI, and shortened colon length (P<0.05) at the three stages. Compared with the normal group, the model group showed elevated levels of IL-1β, IL-6, and TNF-α (P<0.05) at the proliferation stage and elevated levels of CA199 at the inflammation, proliferation, and tumorigenesis (P<0.01) stages. Compared with the normal group, the model group presented obvious infiltration of inflammatory cells at the inflammation stage, thickening of the muscle layer and abnormal proliferation of mucosal layer cells at the proliferation and tumorigenesis stages, and final formation of advanced intraepithelial tumor lesions. Compared with the model group, the Huangqintang groups showed no significant improvement in the body weight, decreased DAI score, and increased colon length at the three stages, and the increase of colon length in the tumorigenesis stage was significant (P<0.01). At the tumorigenesis stage, the administration of Huangqintang inhibited tumor formation and growth, reduced the number of tumors (P<0.01), lowered the levels of IL-6 (P<0.05, P<0.01), TNF-α (P<0.05, P<0.01), and IL-1β at the three stages, and decreased CA199 at the inflammation stage as well as at the proliferation and tumorigenesis stages (P<0.01, P<0.05). Compared with the model group, the administration of Huangqintang reduced inflammation and abnormal cell proliferation, delaying the occurrence of tumors. Compared with the normal group, the model group showcased decreased alpha and beta diversity and altered structure of gut microbiota at the inflammation, proliferation, and tumorigenesis stages. The administration of Huangqintang adjusted the abundance and diversity of gut microbiota to the normal levels. At the inflammation stage, Huangqintang positively regulated two differential phyla (Firmicutes and Bacteroidetes) and three differential genera (Muribaculaceae, Rikenellaceae_RC9_gut_group, and Flavonifractor) in mice. At the proliferation stage, Huangqintang positively regulated two differential phyla (Bacteroidetes and Patescibacteria) and five differential genera (Muribaculaceae, Rikenellaceae_RC9_gut_group, Candidatus_Saccharimonas, norank_f__UCG-010, and Allobaculum). At the tumorigenesis stage, Huangqintang positively regulated two differential phyla (Proteobacteria and Patescibacteria) and eight differential genera (Muribaculaceae, Candidatus_Saccharimonas, norank_f_UCG-010, Lachnospiraceae_UCG-006, Allobaculum, Bacteroides, Lachnospiraceae_NK4A136_group, and Flavonifractor) in mice.ConclusionHuangqintang can intervene in the AOM/DSS-induced transformation of inflammation to CAC in mice by correcting inflammation and short-chain fatty acid-related microbiota disorders.  
      关键词:16S rRNA;gut microbiota;inflammation;inflammation-carcinoma transformation;Huangqintang   
      15
      |
      17
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74699368 false
      发布时间:2024-11-01
    • 最新研究发现,甘麦大枣汤能有效治疗乳腺癌相关抑郁,通过调节免疫炎症和神经递质平衡发挥作用。
      LIU Jieyuan,WANG Yanli,NIU Delian,LI Mengting,DONG Lijinchuan,LIU Xinmin,HOU Hongping,ZHANG Guangping,CHEN Ying,PENG Bo
      Vol. 30, Issue 23, Pages: 170-178(2024) DOI: 10.13422/j.cnki.syfjx.20242122
      摘要:ObjectiveTo investigate the therapeutic effect of Ganmai Dazao Tang on breast cancer-related depression and explore the mechanism of the decoction in regulating immune inflammation and neurotransmitters via the mitogen-activated protein kinase (MAPK)/nuclear factor-κB (NF-κB) pathway.MethodBALB/c mice were randomized into control, model, fluoxetine (5 mg·kg-1·d-1), and low- and high-dose (crude drug 20 and 40 g·kg-1, respectively) Ganmai Dazao Tang groups (n=10). The mouse model of 4T1 orthotopic transplantation-induced breast cancer-related depression-like behavior was established. The depression-like behavior of mice was assessed by the tail suspension test and the forced swimming test. RT-qPCR was employed to determine the mRNA levels of interleukin (IL)-17A, forkhead box P3 (FoxP3),IL-1β, IL-6, and tumor necrosis factor-α (TNF-α) in the cerebral cortex. Flow cytometry was employed to measure the proportions of immune cell subsets in the spleen and thymus. HPLC-MS/MS was employed to measure neurotransmitter levels in the cerebral cortex. Western blotting was employed to detect the activation of the MAPK/NF-κB pathway.ResultCompared with the model group, administration of Ganmai Dazao Tang at a dose of 40 g crude drug·kg-1 continuously for 4 weeks shortened the immobility time of modeled mice in the tail suspension and forced swimming tests (P<0.05), down-regulated the mRNA levels of IL-1β, IL-17A, and TNF-α (P<0.05), increased the proportions of T cells, CD4+ T cells, B cells, helper T 17 (Th17) cells, and regulatory T (Treg) cells, and reduced the proportion of CD8+ T cells (P<0.05). Furthermore, it lowered the levels of 5-hydroxyindoleacetic acid (5-HIAA) and kynurenine (Kyn), decreased the kynurenine/tryptophan (Kyn/Trp) ratio (P<0.05), increased the content of 5-hydroxytryptamine (5-HT), and down-regulated the protein levels of phosphorylated extracellular signal-regulated kinase (p-ERK), phosphorylated p38 MAPK, and phosphorylated nuclear factor-κB p65 (P<0.05).ConclusionGanmai Dazao Tang can down-regulate the expression of inflammatory cytokines such as IL-1β, IL-17A, and TNF-α, restore 5-HT metabolism and Kyn/Trp balance, increase the 5-HT content, and reduce the activation of p38 MAPK, ERK, and the MAPK-mediated NF-κB signaling pathway to reduce neuroinflammation in the treatment of cancer-related depression.  
      关键词:Ganmai Dazao Tang;depression;kynurenine/tryptophan (Kyn/Trp);neuroinflammation;p38 mitogen-activated protein kinase (p38 MAPK)/nuclear factor-κB (NF-κB)   
      14
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74699415 false
      发布时间:2024-11-01
    • 最新研究发现,青藤碱能有效抑制人脑胶质瘤生长,降低肿瘤侵袭,维持血脑屏障完整,并在肿瘤内具有线性药代动力学特征。
      JIAO Yue,JIANG Yumao,WANG Danqiao,WANG Jingyi,LIU Yang,ZHAO Xiaoliang,WANG Zhiguo,LI Tao
      Vol. 30, Issue 23, Pages: 179-186(2024) DOI: 10.13422/j.cnki.syfjx.20241442
      摘要:ObjectiveTo observe the inhibitory effect of sinomenine on human glioblastoma and its pharmacokinetic characteristics in glioblastoma.MethodA human glioblastoma U87 cell line stably expressing luciferase was constructed, and a mouse glioma model was established for use in both pharmacodynamic and pharmacokinetic studies. Pharmacodynamics: Model mice were randomly divided into model group and sinomenine low-, medium-, and high-dose groups (50, 100, 150 mg·kg-1). Sinomenine was administered intraperitoneally for 14 days. The fluorescence value of brain tumors was observed to analyze its inhibitory effect on glioblastoma proliferation. Brain tumors and the surrounding brain tissue were collected, and the expression levels of vascular endothelial growth factor A (VEGFA), P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), and Occludin were detected by Western blot. Pharmacokinetics: Mice were divided into a normal group (50 mg·kg-1) and model groups (50, 100, 150 mg·kg-1). After a single intraperitoneal injection of sinomenine, extracellular fluid from brain tumors was collected in vivo by microdialysis every 15 min for 6 h. Sinomenine concentrations in the dialysate were detected by HPLC-MS/MS, and pharmacokinetic parameters were calculated to analyze pharmacokinetic characteristics of sinomenine in the brain and glioblastoma.ResultCompared with model group, after 14 days of sinomenine administration, the fluorescence value of brain tumors significantly decreased (P<0.05) in a dose-dependent manner. Sinomenine inhibited the increase in VEGF and the degradation of Occludin in the tissue surrounding the tumor and inhibited the expression of VEGF, P-gp, and BCRP in glioblastoma. After a single administration, sinomenine was detected in brain and tumor tissues within 7.5 min. Compared with normal group, the Cmax and AUC in the tumor significantly increased, Tmax shortened (from 1.63 h to 0.71 h), and CLz/F decreased. In the dose range of 50-150 mg·kg-1, sinomenine exhibited a linear pharmacokinetic process in glioblastoma.ConclusionSinomenine has a significant inhibitory effect on glioblastoma, which can inhibit VEGF elevation and drug transporter efflux, reduce tumor invasion, and maintain the integrity of the blood-brain barrier. Sinomenine can rapidly cross the blood-tumor barrier, reach peak concentration, and exhibit linear pharmacokinetic characteristics in the tumor.  
      关键词:sinomenine;human glioblastoma;blood-tumor barrier;pharmacokinetics   
      13
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74698261 false
      发布时间:2024-11-01
    • 最新研究发现,延胡索乙素通过调节谷胱甘肽代谢、铁死亡等多条代谢途径,有效缓解慢性疼痛。
      WU Dan,ZHANG Junhong,FU Lu,ZHONG Yute,WANG Ping,XU Haiyu
      Vol. 30, Issue 23, Pages: 187-194(2024) DOI: 10.13422/j.cnki.syfjx.20241516
      摘要:ObjectiveTo elucidate the underlying mechanism of the efficacy of Levo-tetrahydropalmatine (l-THP) in alleviating chronic pain and identify the key metabolites and metabolic pathways for l-THP regulation.MethodA classical chronic constrictive injury (CCI) model was built in rats’ bodies, and the pain intensity was evaluated by detecting the mechanical withdrawal threshold. On the sixth day after surgery, oral administration of l-THP (64 mg·kg-1) and positive control drug pregabalin (Pre, 30 mg·kg-1) was performed on rats. After the last administration following consecutive five times of administration, ipsilateral spinal cord tissues were collected for widely-targeted metabonomics, with eight rats in each group. Differential metabolites (DEMs) were identified according to the standard of VIP>1.0 and P<0.05, and functional enrichment and interaction analyses of the Kyoto Encyclopedia of Genes and Genomes (KEGG) were performed to obtain the key metabolites and metabolic pathways associated with the analgesic effects of l-THP.ResultIn behavioral science, administration of both l-THP and Pre significantly improved mechanical hyperalgesia in CCI rats (P<0.01), thus mitigating pain. Metabonomic analysis results revealed that l-THP administration corrected the aberrant metabolic profile in the spinal cord of CCI rats. Meanwhile, 53 DEMs were called back, including several classical pain biomarkers such as sphingosine-1-phosphate (S1P), cyclic adenosine monophosphate (cAMP), acetylcholine, and glutamate. Functional enrichment analysis of the DEMs indicated the involvement of metabolic pathways such as ferroptosis, autophagy, neuroactive ligand-receptor interactions, phospholipase D and cAMP-related signaling pathways, glutathione metabolism, and cofactor biosynthesis in mediating the effects of l-THP on the metabolic profile of the spinal cord. Further analyses on the relative metabolite abundance and metabolic pathways indicated that by significantly decreasing the relative levels of glutamate (P<0.01) and glycine (P<0.01) in the spinal cord, l-THP can promote the synthesis of reduced glutathione (GSH) and increase the ratio of reduced/oxidized GSH (P<0.05). Additionally, it can relieve oxidative stress in the spinal cord of CCI rats and significantly reduce the acetyl-CoA level (P<0.01) to finally inhibit ferroptosis occurrence.Conclusionl-THP may exert analgesic effects by regulating multiple metabolic pathways including GSH metabolism, ferroptosis, cofactor biosynthesis, and amino acid synthesis to correct the aberrant metabolic profile in the spinal cord of CCI rats. Ferroptosis and GSH metabolism may be the key pathways for l-THP regulation, with glutamate, glycine, glutathione, and acetyl-CoA as the key metabolites.  
      关键词:levo-tetrahydropalmatine;chronic pain;widely-targeted metabolomics;glutathione metabolism;ferroptosis   
      10
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74704524 false
      发布时间:2024-11-01
    • 最新研究发现,茯苓运化颗粒能改善2型糖尿病大鼠症状,可能通过调节氨基酸类代谢和视黄醇代谢等通路发挥作用。
      TIAN Mengyao,LUO Keke,WANG Mengxiao,HU Tianbao,LI Hongmei,HE Zongyuan,YANG Lixin,HAO Liyu,SI Nan,LIU Yuyang,BIAN Baolin,WANG Hongjie,ZHOU Yanyan
      Vol. 30, Issue 23, Pages: 195-204(2024) DOI: 10.13422/j.cnki.syfjx.20250661
      摘要:ObjectiveBased on non-targeted metabolomics, to analyze the regulation of endogenous differential metabolites in serum of type 2 diabetes mellitus(T2DM) rats by Fuling Yunhua granules, and to clarify the metabolic pathways through which this granules exerted its effect on improving T2DM.MethodSeventy SD rats, half male and half female, were randomly divided into the control group, model group, and high, medium, low dose groups of Fuling Yunhua granules(20.70, 10.35, 5.18 g·kg-1 in raw drug amount) and the positive drug group(pioglitazone hydrochloride tablets, 8.1 mg·kg-1). Except for the control group, other groups were fed with high-sugar and high-fat diet combined with intraperitoneal injection of streptozotocin(STZ) to establish a T2DM rat model. After successful modeling, the treatment groups were administered the corresponding drugs by gavage, and the control group and model group were treated with an equal volume of saline by gavage, once/d, for 28 d. Fasting blood glucose(FBG) and glycosylated hemoglobin A1c(GHbA1c) levels were measured in all groups of rats during the administration period, and hematoxylin-eosin(HE) staining was used to observe the pathomorphological changes in the pancreatic tissues of rats at the end of the administration period. The endogenous metabolite levels in rat serum were detected by ultra-performance liquid chromatography-linear ion trap-electrostatic field orbitrap high-resolution mass spectrometry(UPLC-LTQ-Orbitrap MS), and the data were processed using principal component analysis(PCA) and orthogonal partial least squares-discriminant analysis(OPLS-DA). Differential metabolites were identified by the Human Metabolome Database(HMDB) and the Kyoto Encyclopedia of Genes and Genomes(KEGG), and screened for differential metabolites with variable importance in the projection(VIP) value>1, P<0.05, and fold change(FC)<0.6 or FC>1. And the metabolic pathway enrichment analysis of the screened differential metabolites was performed by MetaboAnalyst 5.0, then the screened differential metabolites were diagnosed and evaluated by the receiver operating characteristic(ROC) curves.ResultCompared with the control group, the FBG level of rats in the model group increased significantly(P<0.01), the GHbA1c content tended to increase, but the difference was not statistically significant, and the pancreatic tissue of rats was obviously damaged, the number of pancreatic islets decreased, and the pancreatic β-cells were obviously reduced, atrophied and enlarged. Compared with the model group, the FBG levels of rats in the high dose group of Fuling Yunhua granules and the positive drug group were significantly reduced after 2 weeks of administration(P<0.05, P<0.01), the GHbA1c content of rats in the high dose group of Fuling Yunhua granules was significantly reduced(P<0.05), and the pancreatic tissue lesions of rats in the different dose groups of Fuling Yunhua granules were reduced. The results of non-targeted metabolomics showed that 46 differential metabolites were significantly changed in the model group compared with the blank group. Pathway enrichment analysis found that T2DM mainly affected biological processes including biosynthesis of primary bile acid, D-amino acid metabolism, steroid hormone biosynthesis, and glycerophospholipid metabolism in rats. Compared with the model group, the levels of 8 differential metabolites in the high dose group of Fuling Yunhua granules were significantly adjusted, and the pathway enrichment analysis found that D-amino acid metabolism, retinol metabolism, glycine, serine and threonine metabolism, tryptophan metabolism and other metabolic pathways were mainly involved. ROC curves further analysis revealed that the four characteristic differential markers of 11-cis-retinol, D-piperidinic acid, D-serine, and p-cresol sulfate had high diagnostic value for the treatment of T2DM with Fuling Yunhua granules.ConclusionFuling Yunhua granules can improve the symptoms of T2DM rats by regulating the amino acid metabolic and retinol metabolic pathways through the modulation of endogenous differential metabolites.  
      关键词:Fuling Yunhua granules;type 2 diabetes mellitus;ultra-performance liquid chromatography-linear ion trap-electrostatic field orbitrap high-resolution mass spectrometry(UPLC-LTQ-Orbitrap MS);non-targeted metabolomics;receiver operating characteristic curve   
      6
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 76305725 false
      发布时间:2024-11-01
    • 最新研究发现,狼毒内生真菌Talaromyces sp. TP21次级代谢产物具有抗癌和抑菌活性,为相关药物研发提供新思路。
      WANG Zimo,LIU Bo,WANG Xiaoqing,ZHANG Dandan,ZHANG Xuan,KANG Yanan,SUN Yi
      Vol. 30, Issue 23, Pages: 205-213(2024) DOI: 10.13422/j.cnki.syfjx.20241415
      摘要:ObjectiveTo study the bioactive secondary metabolites of Talaromyces sp. TP21 and their bioactivities.MethodThe secondary metabolites of Talaromyces sp. TP21 were isolated by high performance liquid chromatography (HPLC), normal phase and reversed phase column chromatography combined with molecular networking and bioassay-guided fractionation, and their structures were determined by nuclear magnetic resonance (NMR) and high resolution mass spectrometry (HR MS). The inhibitory effects of the compounds on the growth of the lung cancer cell line A549 and the liver cancer cell line Hep G2 were measured by themethyl thiazolyl tetrazolium (MTT) method. The antimicrobial activities of the compounds were measured with Staphylococcus aureus and human oral cavity-derived Saccharomyces cerevisiae as the indicator microorganisms.ResultSeventeen compounds were isolated from the secondary metabolites of Talaromyces sp. TP21 and identified as ergochrome C (1), daldiniaeschsone A (2), seco-blennolide B (3), penitholabene (4), penicichrysogene A (5), orsellinic acid (6), griseofulvin (7), isorhodoptilometrin (8), (+)-5-chloromitorubrinic acid (9), penicillixanthone A (10), pentacecilide B (11), pentacecilide C (12), chrodrimanin C (13), chrodrimanin E (14), chrodrimanin H (15), chrodrimanin F (16), and 3-hydroxypentacecilide A (17).ConclusionCompounds 1-5, 11-12, and 17 were isolated from Talaromyces for the first time. Among them, compounds 4, 7, and 10-12 exhibited inhibitory activities against the growth of A549 and Hep G2 cells, with the median inhibitory concentration below 50 μmol·L-1. Furthermore, compounds 9 and 10 showed inhibitory activities against S. aureus and human oral cavity-derived S. cerevisiae, with the minimum inhibitory concentration of 8-128 mg·L-1.  
      关键词:stellera;endophytic fungus;Talaromyces sp.;secondary metabolites;anti-tumor activity;antimicrobial activity   
      10
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74704409 false
      发布时间:2024-11-01
    • 最新研究发现,复方鳖甲软肝片通过调节HMGB1-BDNF互作轴改善酒精性肝病,为临床治疗提供实验证据。
      LIU Yudong,YAN Xiangying,LI Tao,ZHANG Chu,CAI Bingbing,MA Zhaochen,LIN Na,ZHANG Yanqiong
      Vol. 30, Issue 23, Pages: 214-223(2024) DOI: 10.13422/j.cnki.syfjx.20241638
      摘要:ObjectiveTo systematically and objectively characterize the pharmacological effects of Fufang Biejia Ruangan pills (FBRP) in the intervention of alcoholic liver disease (ALD) using acute and chronic ALD mouse models and to elucidate its molecular mechanisms.MethodFifty SPF-grade male BALB/c mice were randomly divided into the normal group, model group, and FBRP low-, medium-, and high-dose groups (9.6, 19.2, 38.4 mg·kg-1). Except for the normal group, the remaining groups were given 56° white wine by gavage to establish the acute ALD model, with samples collected after 4 weeks. Thirty SPF-grade male C57BL/6N mice were randomly divided into the normal group, model group, and FBRP medium-dose group (19.2 mg·kg-1). The chronic ALD mouse model was established using the Lieber-DeCarli method over a 10-week period. Inflammatory markers in liver tissues were assessed using hematoxylin-eosin (HE), Sirius Red, oil red O staining, and enzyme-linked immunosorbent assay (ELISA). Intoxication behaviors of each group were objectively evaluated through sobering-up time, net-catching, and pole-climbing tests. Further bioinformatics analyses based on clinical transcriptomic data were conducted to identify key targets and molecular mechanisms of FBRP in alleviating ALD through liver-brain dialogue, with experimental validation by ELISA, Western blot, and immunohistochemical staining.ResultCompared with the normal group, the levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in liver tissues of mice in the acute and chronic ALD model groups were significantly increased (P<0.05). Compared with the model group, the levels of AST and ALT in liver tissue of mice in FBRP groups were significantly decreased (P<0.05). Compared with the normal group, the time of grasping the net and climbing the pole in the acute ALD model group was significantly decreased within 4 weeks (P<0.01). Compared with the model group, the grasping and climbing time of FBRP high dose groups increased significantly within 4 weeks (P<0.05). Compared with the normal group, the expression of high mobility group protein B1 (HMGB1) protein in liver tissue and prefrontal lobe tissue of mice in the chronic ALD model group was significantly increased (P<0.01). Compared with the model group, the expression of HMGB1 protein in FBRP medium dose group was significantly decreased (P<0.05,P<0.01). Compared with the normal group, the expression of brain-derived neurotrophic factor (BDNF) protein and the release of γ-aminobutyric acid (GABA) in the prefrontal cortex of the model group were significantly decreased (P<0.01). Compared with the model group, the expression of BDNF protein and the release of GABA in the FBRP medium dose group were significantly increased (P<0.05).ConclusionThis study revealed that FBRP improved key pathological changes in ALD by modulating liver-brain dialogue mediated by the HMGB1-BDNF axis. These findings provide experimental evidence for the clinical use of FBRP in treating ALD and offer new insights for the development of ALD therapeutic agents.  
      关键词:alcoholic liver disease;liver-brain axis;Fufang Biejia Ruangan pills;γ-aminobutyric acid   
      14
      |
      21
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74698224 false
      发布时间:2024-11-01
    • 最新研究揭示便秘与肺炎存在因果关系,为临床诊疗提供新视角。
      LI Shuran,SUN Jing,SUN Qiyue,BAO Lei,GENG Zihan,ZHAO Ronghua,BAO Yanyan,CUI Xiaolan,LIU Lianlian,GUO Shanshan
      Vol. 30, Issue 23, Pages: 224-229(2024) DOI: 10.13422/j.cnki.syfjx.20250564
      摘要:ObjectiveBidirectional and two-sample Mendelian randomization(MR) method was used to investigate the bidirectional causal relationship between constipation and pneumonia and to understand the potential relationship between the two diseases from a new perspective, providing new targets for future treatment strategies.MethodConstipation and pneumonia datasets were selected from the genome-wide association study(GWAS) website for the European population in 2021. The data related to constipation included 411 623 samples, and the single nucleotide polymorphism(SNP) data were 24 176 599. The pneumonia data contained 480 299 samples with a number of SNPs of 24 174 646. In this study, inverse variance weighting(IVW) was adopted as the main analysis method of MR, supplemented by weighted median method, simple model, weighted model and MR-Egger regression analysis results, and sensitivity analysis was performed to evaluate the robustness of the results.ResultSeventeen SNPs highly correlated with constipation and 12 SNPs highly correlated with pneumonia were finally included. IVW analysis results of forward MR analysis showed that constipation increased the risk of pneumonia{odds ratio(OR)=1.143, 95% confidence interval(CI)[1.045, 1.249], P=0.003}, MR-Egger regression, simple model, weighted model and weighted median analysis all supported the result(P<0.05). IVW analysis by reverse MR analysis showed that pneumonia did not increase the risk of constipation{OR=1.138, 95%CI[0.974, 1.329], P=0.103}, MR-Egger regression, simple model, weighted model and weighted median analysis also supported this result.ConclusionThe bidirectional and dual-sample MR analysis method is used to confirm the causal relationship between constipation and pneumonia from the perspective of genetic variation, while there is no obvious causal relationship on the contrary. This study will be helpful for the clinical diagnosis and treatment of constipation and pneumonia, and provide a reference for the study of the pathogenesis between the two.  
      关键词:constipation;pneumonia;bidirectional mendelian randomization;causal relationship;intestinal flora;lung-intestinal axis   
      23
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74686155 false
      发布时间:2024-11-01
    • 最新研究发现,全身体积描记系统可准确计数咳嗽次数,构建辣椒素诱导的豚鼠咳嗽模型。白果新化合物GK-A具有止咳作用,可能通过抑制神经肽SP发挥作用。
      GAO Yunhang,JIA Ling,LI Han,SONG Ling,GUO Cong,CHEN Tengfei,HOU Hongping,CHEN Weiya,ZHANG Guangping
      Vol. 30, Issue 23, Pages: 230-236(2024) DOI: 10.13422/j.cnki.syfjx.20241409
      摘要:ObjectiveTo construct a cough model induced by chemical stimuli by whole-body plethysmography (WBP) for counting coughs based on cough waveforms, and use this model to explore the antitussive effect of GK-A.MethodDifferent chemical stimuli were used to induce coughs in mice or guinea pigs. Respiratory waveforms were monitored by WBP, and the recognizable and typical cough waveforms were selected for cough counting. Guinea pigs were induced to cough with different concentrations of citric acid or capsaicin, and cough waveforms were used to optimize the stimulation conditions. The optimized guinea pig model of cough was validated with dextromethorphan, and the optimized guinea pig model of capsaicin-induced cough was used to evaluate the antitussive effect of GK-A.ResultWBP could count the coughs induced by capsaicin and citric acid in guinea pigs by recognizable and typical respiratory waveforms. The optimized stimulation conditions were capsaicin concentration of 100 µmol·L-1 and nebulization for 2 min. The validation results showed that compared with the model group, the dextromethorphan group of guinea pigs had reduced coughs (P<0.05) and prolonged cough latency (P<0.01). GK-A prolonged the cough latency (P<0.05) and reduced coughs (P<0.05) in the mouse model of ammonia-induced cough. In the guinea pig model of capsaicin-induced cough, GK-A prolonged cough latency (P<0.05), reduced coughs (P<0.05), and decreased substance P (SP) content in the guinea pig serum (P<0.05, P<0.01).ConclusionA guinea pig model of capsaicin-induced cough was successfully established based on cough waveform counting, which provided an objective and accurate cough counting method. GK-A has antitussive effects, possibly by inhibiting the neuropeptide SP.  
      关键词:guinea pig model of cough;whole-body plethysmography (WBP);capsaicin;GK-A;antitussive effect   
      12
      |
      4
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74718777 false
      发布时间:2024-11-01
    • 最新研究发现,戊己丸通过调节PPARγ信号通路和T细胞免疫,有效减轻大鼠炎症性肠病症状,为中医药治疗IBD提供新思路。
      GUO Shiyun,GUO Yuxuan,SUN Yi,ZHU Xiaoxin,LI Yujie,CHEN Ying,YANG Qing,WANG Yajie,LI Qi,WENG Xiaogang,DENG Zhihao
      Vol. 30, Issue 23, Pages: 237-245(2024) DOI: 10.13422/j.cnki.syfjx.20241644
      摘要:ObjectiveThis study explores the efficacy and pharmacological mechanism of Wujiwan in rats with inflammatory bowel disease (IBD) from the perspectives of the peroxisome proliferator-activated receptor γ (PPARγ) signaling pathway and T-cell immunity, providing reference for the treatment of IBD with traditional Chinese medicine.MethodThe study involved administering 2,4,6-trinitrobenzenesulfonic acid (TNBS) enemas to 35 rats to induce acute IBD. After 24 hours, the animals were divided into the following groups: normal group, model group, Wujiwan treatment group, and positive drug control group. Each group received gastric gavage for 8 consecutive days before the rats were dissected to compare the disease activity index (DAI) of the rat colon tissue, the colon mucosal damage index (CMDI), and the spleen index. Enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of interleukin-1β (IL-1β), interleukin-10 (IL-10), and tumor necrosis factor-α (TNF-α) in the serum. Quantitative real-time polymerase chain reaction (Real-time PCR) was used to determine the mRNA expression levels of T-bet (T-box expressed in T cells) and Gata3 (Gata-binding protein-3) in the colon tissue. Western blot analysis was conducted to detect the protein expression levels of PPARγ, T-bet, and nuclear factor-κB p65 (NF-κB p65) in the rat colon.ResultThe rat model of IBD was successfully established. Compared with the model group, the Wujiwan treatment group showed reduced DAI, CMDI, and spleen index, decreased content of TNF-α in the serum(P<0.01), significantly increased content of IL-10(P<0.01), and elevated mRNA content of T-bet and Gata3(P<0.05) in the colon tissue. The expression of PPARγ protein was augmented(P<0.05), and the expression of T-bet and NF-κB p65 protein was decreased(P<0.05,P<0.01).ConclusionWujiwan activates or upregulates PPARγ expression in IBD rats to inhibit the generation of pro-inflammatory factors, participates in the inflammatory immune process, and alleviates inflammatory reactions. Its mechanism may involve regulating the NF-κB pathway through PPARγ, enhancing Th2 cell transcription expression, and reducing Th1 cell transcription.  
      关键词:Wujiwan;inflammatory bowel disease (IBD);peroxisome proliferator-activated receptor γ (PPARγ);T-cell   
      13
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74698323 false
      发布时间:2024-11-01
    • 最新研究发现,炆何首乌能有效改善雄激素性脱发,其机制涉及降低雄性激素水平和促进Wnt/β-catenin信号传导。
      PAN Fuzhu,CHEN Mingxia,YI Bin,XUE Yanhua,YU Qiuping,WU Fayun,JI Enhui,WU Hongwei,XU Jing
      Vol. 30, Issue 23, Pages: 246-253(2024) DOI: 10.13422/j.cnki.syfjx.20241003
      摘要:ObjectiveTo evaluate the therapeutic effect of stewed Polygoni Multiflori Radix on androgenic alopecia (AGA) and study the treatment mechanism.MethodNinety-nine SPF-grade male C57BL/6J mice were randomized into control, model, positive drug (finasteride, 0.65 mg·kg-1), low (0.78 g·kg-1), medium (1.56 g·kg-1), and high (3.12 g·kg-1)-dose stewed Polygoni Multiflori Radix, and Polygoni Multiflori Radix Praeparata groups by the random number table method. The mouse model of AGA was constructed by subcutaneous multi-point injection of testosterone propionate diluent for 60 days, and the mice were administrated with corresponding drugs by gavage from day 11. The therapeutic effects of stewed Polygoni Multiflori Radix and Polygoni Multiflori Radix Praeparata on AGA were evaluated by newly hair area, hair length, hair weight in the hair removal area, and hematoxylin-eosin staining. Enzyme-linked immunosorbent assay was employed to determine the levels of testosterone (T), dihydrotestosterone (DHT), and 5α-reductase (5-AR) in the skin tissue of mice. Western blot was employed to determine the expression levels of key proteins in the Wnt/β-catenin signaling pathway.ResultCompared with the control group, the model group (after 60 days of modeling) showed reductions in the newly hair area, hair length and weight in the back hair removal area, and ratio of hair follicles containing melanin to total hair follicles (P<0.05, P<0.01), elevated levels of T, DHT, and 5-AR, up-regulated expression level of glycogen synthase kinase-3β (GSK-3β) (P<0.05, P<0.01), and down-regulated expression levels of β-catenin, phospho-glycogen synthase kinase-3β (p-GSK-3β), and p-GSK-3β/GSK-3β (P<0.05, P<0.01) in the skin tissue. Compared with the model group, the positive drug, low-, medium-, and high-dose stewed Polygoni Multiflori Radix, and low-, medium-, and high-dose Polygoni Multiflori Radix Praeparata improved the newly hair area and hair length of mice (P<0.01), and stewed Polygoni Multiflori Radix and Polygoni Multiflori Radix Praeparata at low and medium doses improved the weight of newly formed hair in mice (P<0.05, P<0.01). The positive drug, low-, medium-, and high-dose stewed Polygoni Multiflori Radix, and low- and high-dose Polygoni Multiflori Radix Praeparata increased the ratio of hair follicles containing melanin to total hair follicles in the skin tissue (P<0.05, P<0.01). Compared with Polygoni Multiflori Radix Praeparata at the same doses, the medium and high doses of stewed Polygoni Multiflori Radix increased the ratio of melanin-containing hair follicles to total hair follicles (P<0.05). Compared with the model group, stewed Polygoni Multiflori Radix lowered the levels of T and DHT, down-regulated the expression level of GSK-3β (P<0.01), and up-regulated the expression levels of β-catenin, p-GSK-3β, and p-GSK-3β/GSK-3β (P<0.05, P<0.01) in the skin tissue of the mice.ConclusionStewed Polygoni Multiflori Radix can ameliorate androgenic alopecia in mice by reducing the androgen level and promoting Wnt/β-catenin signaling.  
      关键词:stewed Polygoni Multiflori Radix;Polygoni Multiflori Radix Praeparata;androgenic alopecia;hair regeneration;Wnt/β-catenin signaling pathway   
      11
      |
      19
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74713104 false
      发布时间:2024-11-01
    • 最新研究发现,消渴饮能有效改善ob/ob小鼠胰岛素抵抗,降低胆固醇水平,为糖尿病治疗提供新思路。
      LI Baoying,ZHAO Baosheng,ZHA Yuling,DENG Mi,NIU Luna,LI Xuefei,ZHU Ruowei,DONG Yu,JING Lu
      Vol. 30, Issue 23, Pages: 254-260(2024) DOI: 10.13422/j.cnki.syfjx.20242321
      摘要:ObjectiveTo observe the effect of Xiaoke drink on insulin resistance in ob/ob mice and explore the mechanism.MethodEighteen ob/ob mice were randomly assigned into model, Xiaoke drink (17.68 g·kg-1), and atorvastatin (0.01 g·kg-1) groups (n=6), and six C57BL/6 mice were selected as the normal group. Mice in the normal and model groups were administrated with the same amount of distilled water. Fasting body weight, weekly food intake, and weekly water intake were measured at a fixed time. Fasting plasma glucose (FPG) and 2-hour post-load plasma glucose (2 hPG) were measured before and after 8-week intervention. After intervention, total cholesterol (TC), triglyceride (TG), fasting insulin (FINS), Homeostasis Model Assessment-Insulin Resistance (HOMA-IR), blood routine, and alkaline phosphatase (ALP) were measured. Western blot was employed to determine the expression levels of ubiquitin-specific protease 20 (USP20) and 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) in the liver. The pancreas was stained with hematoxylin-eosin for observation.ResultCompared with the model group, the Xiaoke drink group showed decreased body weight of ob/ob mice (P<0.05, P<0.01), declined growth trend of body weight (P<0.05, P<0.01), reduced weekly average water intake, lowered levels of FPG, 2 hPG, TC, and HOMA-IR (P<0.05, P<0.01), and down-regulated expression level of USP20 in the liver (P<0.05). HMGCR content was positively correlated with USP20 expression. In addition, Xiaoke drink promoted the recovery of islet tissue morphology and function in ob/ob mice.ConclusionXiaoke drink can ameliorate insulin resistance in ob/ob mice by inhibiting USP20/HMGCR expression, reversing cholesterol biosynthesis process, and reducing cholesterol level.  
      关键词:Xiaoke drink;ob/ob mice;insulin resistance;cholesterol;mechanism   
      13
      |
      4
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74699466 false
      发布时间:2024-11-01
    • 疏风解毒胶囊在调节免疫细胞比例和炎症因子水平方面取得积极进展,为上呼吸道感染等疾病治疗提供新方向。
      LI Xinying,BAO Lei,SUN Jing,LI Shuran,ZHAO Ronghua,BAO Yanyan,CUI Xiaolan,GUO Shanshan,GENG Zihan
      Vol. 30, Issue 23, Pages: 261-268(2024) DOI: 10.13422/j.cnki.syfjx.20241301
      摘要:Shufeng Jiedu capsules, a Chinese patent medicine composed of Polygoni Cuspidati Rhizoma et Radix, Forsythiae Fructus, etc., has shown positive effects in the clinical treatment of upper respiratory tract infections, pharyngitis, acute exacerbation of chronic obstructive pulmonary disease (AECOPD), and coronavirus disease 2019 (COVID-19). The available evidence suggests that Shufeng Jiedu capsules can modulate the proportions of immune cells and the concentrations of inflammatory cytokines, thereby easing symptoms and enhancing cure rates. The existing reviews predominantly focus on the clinical applications of Shufeng Jiedu capsules, while the comprehensive review of the immunomodulatory effect of this medicine remains to be carried out. This review delineates the immune responses triggered by respiratory tract infections, and then summarizes the clinical application of Shufeng Jiedu capsules and its main chemical components. Principally, this review summarizes the immunomodulatory and anti-inflammatory mechanisms, mainly focusing on various immune cells including macrophages, neutrophils, natural killer (NK) cells, and lymphocytes. In addition, this paper discusses the influences of Shufeng Jiedu capsules and its main chemical components on signaling pathways, secretion of pro-inflammatory cytokines, and antibody production. In terms of innate immunity, the intervention effects of Shufeng Jiedu capsules are highlighted by its capacity to inhibit the activation of nuclear factor kappa-B (NF-κB) and interferon regulatory factor 3 (IRF3) pathways. Additionally, Shufeng Jiedu capsules have been shown to reduce the expression of microtubule-associated protein 1 light chain 3 Ⅱ (LC3Ⅱ), thereby suppressing the inflammation and autophagy of macrophages. Furthermore, the influence of this medicine extends to altering the proportions of neutrophils and nature killer(NK) cells. Regarding adaptive immunity, Shufeng Jiedu capsules can increase the proportion of T cells in peripheral blood and restore the balance of B cells. This review aims to provide directions for the further research and clinical application of Shufeng Jiedu capsules.  
      关键词:respiratory tract infections;pneumonia;Shufeng Jiedu capsules;immunomodulation;reaserch progress   
      15
      |
      5
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74718120 false
      发布时间:2024-11-01
    • 最新报道显示,肾虚证研究在临床与动物实验方面取得显著进展,涉及神经内分泌免疫网络等多条信号通路及生化指标,为肾虚证诊断提供重要参考。
      LIU Guimin,SUN Jianhui,LI Jianliang,YU Zeyue,HAO Liyu,HUANG Hanhui,LI Zongyuan,WANG Aoao,YANG Yang,LI Hongmei
      Vol. 30, Issue 23, Pages: 269-280(2024) DOI: 10.13422/j.cnki.syfjx.20241605
      摘要:Kidney deficiency syndrome is a common clinical syndrome in traditional Chinese medicine (TCM). With the progress of science and technology, clinical and animal experiments on kidney deficiency syndrome have made remarkable progress. Research on kidney deficiency and the nature of "kidney" involves a large number of physiological and pathological bases, which are closely related to physiological and pathological links in the human body, among which the neuroendocrine-immune network shares the closest relationship. However, there are still many challenges in modern research on kidney deficiency syndrome, such as expert consensus on clinical diagnostic criteria and evaluation indexes and optimization of animal experimental models. In the past decade, a large number of clinical and animal experiments have been reported in the literature on kidney deficiency syndrome, among which the literature focusing on the combination of disease and syndrome is predominant, and most of them focus on kidney Yang deficiency and kidney Yin deficiency, involving the exploration of many pathological mechanisms. Research on the mechanisms related to kidney deficiency syndrome encompasses multiple signaling pathways and various biochemical indicators, including the phosphatidylinositol 3-kinase/protein kinase B/nuclear factor-erythroid 2-relatedfactor-2(PI3K/Akt/Nrf2) signaling pathway, the Toll-like receptor 4/myeloid differentiation factor88/nuclear factor-κB(TLR4/MyD88/NF-κB) signaling pathway, the Janus kinase 2/signal transducer and activator of transcription 3(JAK2/STAT3) signaling pathway, Osteoprotectin/nuclear factor-κB receptor activator ligand/receptor activator of nuclear factor-κB (OPG/RANKL/RANK) signaling pathway. The biochemical indicators cover the cyclic adenosine monophosphate/cyclic guanosine monophosphate (cAMP/cGMP) ratio, Na+-K+-ATPase activity, Ca2+-Mg2+-ATPase activity, adrenocorticotropic hormone (ACTH), polycorticosterone (CORT), 17-OHCS, and other sex hormone indicators, providing crucial reference values for diagnosing kidney Yang deficiency or kidney Yin deficiency. The literature related to kidney deficiency syndrome over the past decade was collated and excavated, with a view to providing a reference for research on kidney deficiency syndrome.  
      关键词:kidney deficiency syndrome;combination of disease and syndrome;clinical research;animal research;pathological mechanism;biochemical indicators;research progress   
      11
      |
      4
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74718217 false
      发布时间:2024-11-01
    • 最新研究揭示了表观遗传调控在肝癌发生发展中的作用机制,中医药实验研究成果为肝癌诊疗提供新思路。
      XU Xianyu,ZHU Yongping,LIU Yanqing,GU Liwei,ZHANG Junzhe,SHEN Shengnan,WANG Jigang
      Vol. 30, Issue 23, Pages: 281-291(2024) DOI: 10.13422/j.cnki.syfjx.20250391
      摘要:Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world. In recent years, the clinical early diagnosis and treatment protocols of HCC have been improved, whereas the prognosis of patients is still not satisfactory, which is due to the fact that the mechanism of HCC development has not been fully elucidated. Therefore, it is of great significance to explore the molecular mechanisms and key regulatory links of hepatocellular carcinoma development to further improve the diagnosis and treatment of HCC in China. Epigenetics has become a research hotspot because of its reversibility and easy regulation. According to relevant studies, HCC involves the accumulation of multiple genetic and epigenetic changes during the initiation, promotion, and progression stages. HCC is categorized as infantile malnutrition with accumulation, hypochondriac pain, tympan ites, and abdominal mass in traditional Chinese medicine (TCM). In the treatment of HCC, TCM with low toxicity, multi-targets, and multi-mechanisms can inhibit tumor growth, alleviate the clinical symptoms, and enhance the quality of life of the patients. Chinese medicines and their active ingredients exert anti-HCC effects through epigenetic regulation of DNA methylation, histone modification, and non-coding RNA. Abnormal gene expression due to epigenetic regulation disorders is involved in all stages of HCC development. There are few studies on epigenetic regulation in TCM treatment of HCC, and there is still much room for development in basic and clinical trials. This paper reviews the mechanism of epigenetic regulation in HCC and summarizes the experimental results of TCM research on the related mechanism, with a view to providing a theoretical basis for future research on the mechanism of HCC development and clinical diagnosis and treatment of hepatocellular carcinoma with TCM.  
      关键词:epigenetic;hepatocellular carcinoma;mechanism;traditional Chinese medicine;DNA methylation;histone modification;non-coding RNAs   
      15
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74686065 false
      发布时间:2024-11-01
    • 最新研究发现,青蒿素及其衍生物在神经系统疾病治疗领域具有潜在保护作用,为相关药物研发和临床治疗提供新思路。
      LIANG Yan,QU Shuiqing,LI Yu,DAI Yue,LIU Chengcheng,WANG Luqi,CHEN Lina,LIU Tuo,LI Yujie
      Vol. 30, Issue 23, Pages: 292-299(2024) DOI: 10.13422/j.cnki.syfjx.20241205
      摘要:With the rapid development of social economy, the number of patients with nervous system diseases has increased, and the incidence of the population has a trend of younger, which has a serious impact on life health and social economy. Artemisinin is an active antimalarial component extracted and isolated from Artemisia annua, a Chinese medicinal material. Artemisinin and its derivatives, in addition to the antimalarial effect, also have anti-parasitic, anti-fungal, anti-viral, hypoglycemic, hypolipidemic, anti-tumor, and anti-inflammatory effects, showing a wide range of pharmacological activities. In the past five years, research on the new pharmacological effects of artemisinin and its derivatives has been deepening, and the efficacy of artemisinin and its derivatives in nervous system diseases has attracted much attention, including anti-neuroinflammation, anti-oxidative stress, maintaining the stability of the blood-brain barrier, regulating the release of neurotransmitters, repairing neuronal damage, and promoting neuronal regeneration. These pharmacological effects indicate that artemisinin and its derivatives are potentially capable of neuroprotection. By sorting out literature on the pharmacological activity of artemisinin and its derivatives in nervous system during 2019-2024, this paper systematically summarized the protective effects of artemisinin and its derivatives against nervous system diseases such as stroke, neurodegenerative diseases, neuroimmunological diseases, neuralgia, and nervous system tumors. This review is expected to provide clues and evidence for new indication expansion of artemisinin drugs, innovative drug development, and clinical treatment of nervous system diseases.  
      关键词:artemisinin;artemisinin and its derivatives;nervous system diseases;neuroprotection;pharmacology of Chinese medicine   
      12
      |
      4
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74713078 false
      发布时间:2024-11-01
    • 在类风湿关节炎研究领域,专家基于“亢害承制”理论,从中医角度解析RA的现代医学基础,揭示了中医病机与现代病理机制的内在联系,为RA临床治疗提供理论参考。
      LI Siyu,SONG Changyue,SU Xiaohui,WANG Jingbo,CUI Huantian,KONG Xiangying
      Vol. 30, Issue 23, Pages: 300-307(2024) DOI: 10.13422/j.cnki.syfjx.20241604
      摘要:Rheumatoid arthritis (RA) is a chronic autoimmune disease with a complex pathogenesis. Immune dysfunction, synovial inflammation, and bone destruction are the key pathological links. The theory of "harmful hyperactivity and responding inhibition" is a high-level summary of the coordinated development of things in nature and the generation and restriction of the five elements and the six factors in nature. People and all things have the same origin, and the theory of "harmful hyperactivity and responding inhibition" represents the intrinsic regulation mechanism of the human body's homeostasis, reflecting the unity of opposites of "hyperactivity" and "inhibition" and emphasizing coordination and stabilization. In the pathogenesis of RA, the excessive immune response disrupts the normal body balance, which is closely related to the process of "hyperactivity becoming harmful". Synovial inflammation, tissue hyperplasia, and bone destruction are pathological results of the dysregulation of the body's immune self-stabilization function and can be regarded as the process of "failing to inhibition". Therefore, the theory of "hyperactivity harmful hyperactivity and responding inhibition" provides a unique perspective for understanding the modern pathological mechanisms of RA. Based on the theory of "harmful hyperactivity and responding inhibition" and the pathogenesis of RA, the author analyzed the modern medical basis of RA from the perspective of traditional Chinese medicine (TCM) and revealed the intrinsic connection between TCM pathogenesis such as insufficiency of vital energy and blood, strong defensive Qi and weak nutrient Qi, and intertwined phlegm and blood stasis and modern research on autoimmune disorders, synovial inflammation, and bone destruction. With the therapeutic criterion of "harm inhibition and responsible supporting", the article summarized the mechanism of TCM in calming hyperactivity and supporting invincibility, which provided theoretical references for the clinical treatment of RA.  
      关键词:harmful hyperactivity and responding inhibition;rheumatoid arthritis;immune disorders;synovial inflammation;bone destruction;traditional Chinese medicine   
      11
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74718180 false
      发布时间:2024-11-01
    • 最新研究综述了中西医对呆病中淡漠表现的认识,为临床前致病机制研究与评价提供理论基础,为治疗方案奠定基础。
      DONG Lijinchuan,YANG Qing,ZHU Xiaoxin,LI Qi,PENG Bo,LI Hongmei,CAI Weiyan,CHEN Ying
      Vol. 30, Issue 23, Pages: 308-317(2024) DOI: 10.13422/j.cnki.syfjx.20241419
      摘要:Dementia in traditional Chinese medicine (TCM) mainly presents amnesia and dullness. Alzheimer's disease and vascular dementia belong to the category of dementia in TCM. These progressive neurological diseases have a complex etiology and a long course, and the drugs that can reverse the disease course remain to be developed. Therefore, early intervention plays a vital role in delaying the disease progression. Apathy refers to a lack of motivation that leads to the attenuation or disappearance of goal-directed behaviors, cognitive functions, and emotional responses. Clinical studies have suggested that apathy exists in the early stage of a variety of neurodegenerative diseases, being one of the key symptoms to the early diagnosis of dementia. The severity of apathy is related to the severity of dementia. Therefore, early diagnosis and treatment of apathy are of great significance to the prevention and treatment of dementia. The preclinical research on apathy in dementia is still in its infancy, and the systematic evaluation method has not been prescribed. The clinical diagnosis and treatment are also in the exploratory stage, and the complex pathophysiological mechanisms of apathy and dementia development have not been fully elucidated. This article reviews the research progress of apathy in dementia, the apathetic behaviors of dementia animal models, the behaviors of patients with apathy, and the treatment methods in recent years and summarizes the research status of apathy in dementia. This review aims to provide a theoretical basis for exploring the behavior of apathy in dementia and conducting preclinical research and evaluation of the pathogenesis and to lay a foundation for the treatment of apathy in dementia.  
      关键词:apathy;dementia;animal models;behavioral assessment;drug interventions   
      8
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74704556 false
      发布时间:2024-11-01
    • 最新研究揭示空气污染物通过多种途径加速心血管疾病进程,为防治提供新思路。
      LIU Chengcheng,LI Yu,LIANG Yan,QU Shuiqing,DAI Yue,LIU Tuo,CHEN Lina,WANG Luqi,LI Yujie
      Vol. 30, Issue 23, Pages: 318-326(2024) DOI: 10.13422/j.cnki.syfjx.20241209
      摘要:The impact of air pollution on human health has always been a research hotspot in the global health field. Outdoor air pollutants composed of multiple components can enter the human body through various pathways. Cardiovascular diseases are a group of diseases caused by outdoor air pollutants. Studies have shown that the incidence of cardiovascular diseases, including hypertension, arrhythmia, and heart failure, is significantly increased among people exposed to air pollution environments. Air pollutants such as fine particulate matter, nitrogen dioxide, ozone, carbon monoxide, and sulfur dioxide are closely related to the occurrence of cardiovascular diseases, and short-term and long-term exposure causes different cardiovascular risks. By reviewing the relevant research reports from 2019 to 2024, this article summarizes the epidemiological evidence of cardiovascular diseases caused by different air pollutants. It generalizes the pathways through which air pollutants accelerate the progression of cardiovascular diseases. These pathways include oxidative stress, inflammatory response, thrombosis, extracellular vesicle release, endoplasmic reticulum stress, apoptosis, endothelial dysfunction, autonomic nervous system imbalance, and their interactions. Based on the different mechanisms of air pollution on cardiovascular diseases, the article analyzes the main progress in drug intervention and summarizes the roles of various active ingredients and compound prescriptions of traditional Chinese medicine in treating air pollution-related cardiovascular diseases, providing reference for the research on the mechanisms and drug interventions of air pollution-related cardiovascular diseases.  
      关键词:air pollution;cardiovascular disease;epidemiology;traditional Chinese medicine prevention and treatment   
      17
      |
      3
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74718705 false
      发布时间:2024-11-01
    • 最新研究揭示中药在糖尿病心血管疾病治疗中的多靶点作用,为临床治疗提供新思路。
      ZHANG Yu,LI Yu,ZHENG Zhongyuan,LIANG Yan,LIU Chengcheng,DAI Yue,WANG Luqi,LIU Tuo,CHEN Lina,LI Yujie
      Vol. 30, Issue 23, Pages: 327-337(2024) DOI: 10.13422/j.cnki.syfjx.20242121
      摘要:The complex pathophysiological mechanisms between diabetes mellitus and cardiovascular diseases have not yet been fully elucidated, becoming one of the challenges in clinical care. Glucagon-like peptide-1 receptor agonist (GLP1-RA) and sodium glucose cotransporter-2 inhibitors (SGLT2) are clinically used to reduce the cardiovascular risk of patients with diabetes mellitus. Traditional Chinese medicine has diverse biological activities and unique advantages in the treatment of chronic complex diseases due to its multi-component and multi-target effects. Based on recent reports, this paper reviewed the common risk factors of diabetes mellitus and cardiovascular diseases (e.g., hyperglycemia, insulin resistance, and inflammation), related targets such as apolipoprotein C-Ⅲ (APOC3), S100 calcium-binding protein A8/A9 (S100A8/A9), growth/differentiation factor-15 (GDF-15), and NACHT, LRR, and PYD domains-containing protein 3 (NLRP3), advanced glycation end products, insulin resistance, endothelial dysfunction, endoplasmic reticulum stress, mitochondrial dysfunction, and intestinal flora disorder. In addition, this paper summarized the research progress in the treatment of cardiovascular diseases in diabetes mellitus with the active ingredients (e.g., baicalein, puerarin, curcumin, notoginsenoside, and tanshinone ⅡA), single herbal medicines (e.g., Astragali Radix, Ginseng Radix et Rhizoma, Sophorae Flavescentis Radix, Cinnamomi Cortex, and Corni Fructus), and compound formulas (e.g., Buzang Tongluo Fang, Yiqi Yangyin Huoxue Fang, Shenqi Fang, Huangqisan, Danggui Buxue Tang, and Liuwei Dihuang Wan) of traditional Chinese medicine. Traditional Chinese medicine mainly treats cardiovascular diseases in diabetes mellitus by reducing inflammation and oxidative stress, ameliorating dyslipidemia and insulin resistance, protecting islet β cell function, repairing endothelial damage, inhibiting smooth muscle cell proliferation, foam cell formation, macrophage polarization, and cardiac hypertrophy and fibrosis, and regulating intestinal flora disorder. These processes involve insulin receptor substrate/ phosphatidylinositol 3-kinase/protein kinase B (IRS/PI3K/Akt), peroxisome proliferator-activated receptor α/γ (PPAR α/γ), nuclear factor-kappa B (NF-κB), adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK), hypoxia-inducible factor-1-BCH domain-containing protein (HIF-1-BNIP), vascular endothelial growth factor/hypoxia-inducible factor-1α (VEGF/HIF-1α) and other signaling pathways. This review is expected to provide a theoretical basis and reference for the treatment of cardiovascular diseases in diabetes mellitus with traditional Chinese medicine.  
      关键词:diabetes mellitus;cardiovascular disease;comorbidity factors;mechanisms and targets;traditional Chinese medicine   
      13
      |
      5
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74699338 false
      发布时间:2024-11-01
    • 中医药学历史悠久,中药复方临床应用广泛。现代科技推动中药复方效应复杂性研究,为中医药现代化、国际化提供新理论。
      GUO Shiyun,DENG Zhihao,LI Yan,GUO Yuxuan,ZHU Xiaoxin,LI Yujie,CHEN Ying,YANG Qing,SUN Yi,WANG Yajie,LI Qi,CAI Weiyan,WENG Xiaogang
      Vol. 30, Issue 23, Pages: 338-344(2024) DOI: 10.13422/j.cnki.syfjx.20241645
      摘要:Traditional Chinese medicine (TCM) has a long history of application in China and has consistently played a vital role in treating diseases and saving lives. TCM prescriptions (compounds) constitute the primary form of clinical TCM treatment and significantly differ from western medicine (chemicals) due to the diverse composition and chemical constituents of TCM (compounds). Nevertheless, the potential multi-component, multi-target, and multi-pathway action characteristics of TCM prescriptions also demonstrate their possible (complementary) therapeutic advantages when compared with single-component chemical drugs. Therefore, driven by the development of modern science and technology and the demands of the modernization and internationalization of TCM, modern theories regarding the complexity of TCM prescription effects have been continuously proposed: Different from the abstract language of traditional prescription theory, the modern TCM prescription theory is more inclined to illustrate the connotation of prescription compatibility concretely and vividly from an experimental and scientific perspective. In this paper, new theories on the complexity of TCM prescriptions proposed in recent years are summarized to provide research references and ideas for the greater role of TCM prescriptions and a better scientific understanding.  
      关键词:Chinese materia medica compound;compatibility of traditional Chinese medicine;pharmacological research;drug efficacy study   
      14
      |
      4
      |
      0
      <HTML>
      <H-PDF><L-PDF>
      <引用本文> <批量引用> 74698294 false
      发布时间:2024-11-01
    0